azathioprine has been researched along with tacrolimus in 519 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (0.58) | 18.7374 |
1990's | 176 (33.91) | 18.2507 |
2000's | 199 (38.34) | 29.6817 |
2010's | 121 (23.31) | 24.3611 |
2020's | 20 (3.85) | 2.80 |
Authors | Studies |
---|---|
Fujimoto, H; Ishibashi, M; Kim, YP; Nakamura, E; Okuyama, E; Sassa, T | 1 |
Fujimoto, H; Ishibashi, M; Okuyama, E; Sumino, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Barry, JM | 1 |
Egashira, T; Goto, S; Iwao, Y; Kawano, K; Kim, YI; Kobayashi, M; Ono, M | 1 |
Kahan, BD | 2 |
Allen, RD; Chapman, JR; Griffin, AD; Hawthorne, WJ; Inutsuka, S | 1 |
Ludwig, J; Paya, C; van Hoek, B; Wiesner, RH | 1 |
Lim, SM; White, DJ | 1 |
Goto, S; Kawano, K; Kim, YI; Kobayashi, M; Ono, M | 1 |
Ishibashi, M; Jiang, H; Kameoka, H; Kokado, Y; Li, D; Moutabarrik, A; Okuyama, A; Suguo, H; Takahara, S; Takano, Y | 1 |
Burke, PA; Jenkins, RL; Lewis, WD; Lopez, R; Monaco, AP; Shaffer, D; Winn, KM | 1 |
Gordon, RD; Morel, P; Rilo, HL; Starzl, TE; Todo, S; Tzakis, AG | 1 |
Armitage, JM; Dew, MA; Griffith, BP; Harris, RC; Roth, LH; Simmons, RG | 1 |
Bismuth, H; Callard, P; Fredj, G; Fries, D; Hiesse, C; Meduri, G; Rucay, P; Samuel, D | 1 |
Dumler, F; Schmidt, RJ; Venkat, KK | 1 |
McWhinnie, DL; Morris, PJ | 1 |
Alexander, G; Calne, R; Friend, PJ; Jamieson, NV; Johnston, PS | 1 |
Maruyama, S; Masaki, Y; Matsubayashi, T; Sato, K; Sonoda, K; Takahara, H; Watanabe, K; Yago, K; Yamagishi, K; Yuge, K | 1 |
Ishibashi, M; Jiang, S; Kokado, Y; Sonoda, T; Takahara, S | 1 |
Concepcion, W; Gordon, RD; Iwatsuki, S; Makowka, L; Podesta, L; Starzl, TE; Stieber, A; Todo, S; Tzakis, AG; Yanaga, K | 1 |
Egashira, T; Kai, T; Kawano, K; Kim, YI; Kobayashi, M; Morimoto, A; Shimada, T | 1 |
Beaver, SJ; Crotty, PH; Gores, GJ; Hay, JE; Krom, RA; Porayko, MK; Richards, TM; Steers, JL; Textor, SC; Wiesner, RH | 1 |
Engelbrecht, ME; Myburgh, JA; Oosthuizen, MM | 1 |
Fujisaki, S; Irish, W; Miyazawa, H; Murase, N; Starzl, TE; Tanabe, M; Todo, S | 2 |
Ota, K | 1 |
Chen, CL; Chen, YS; Kuo, YC; Sun, CK | 1 |
Calmus, Y | 1 |
Antoine, M; Estenne, M; Knoop, C; Vachiéry, JL; Yernault, JC | 1 |
Bechstein, WO; Blumhardt, G; Hopf, U; Knoop, M; Langrehr, JM; Lemmens, HP; Lohmann, R; Neuhaus, R; Schattenfroh, N; Verschl, J | 1 |
Demetris, AJ; Fung, J; Irish, W; Jordan, M; McCauley, J; Randhawa, P; Scantlebury, V; Shapiro, R; Tzakis, A; Vivas, C | 1 |
Demetris, AJ; Fung, JJ; Irish, W; Jordan, ML; McCauley, J; Mitchell, S; Randhawa, P; Scantlebury, VP; Shapiro, R; Vivas, C | 1 |
Gonwa, TA; Klintmalm, GB; Porayko, MK; Wiesner, RH | 1 |
Angelin, B; Duraj, F; Einarsson, K; Ericzon, BG; Groth, CG; Söderdahl, G | 1 |
Armstrong, VW; Kaltefleiter, M; Loss, M; Luy-Kaltefleiter, M; Oellerich, M; Ringe, B; Schütz, E; Wieland, E; Winkler, M | 1 |
Hopf, U; Keck, H; Kling, N; Knoop, M; Langrehr, JM; Lemmens, HP; Lohmann, R; Müller, AR; Neumann, U; Platz, KP | 1 |
Bismuth, H | 1 |
Demetris, AJ; Fung, JJ; Irish, W; Jain, A; Jordan, ML; McCauley, J; Randhawa, P; Scantlebury, VP; Shapiro, R; Vivas, C | 1 |
Fujimoto, N; Fukunishi, T; Hanafusa, T; Ichikawa, Y; Ihara, H; Kyo, M; Nagano, S; Nakayama, K; Nishiuchi, M; Shinji, Y | 1 |
Armitage, JM; Fricker, FJ; Swenson, JM | 1 |
Marsh, JW; Perdrizet, GA; So, SK; White, HM; Woodle, ES | 1 |
Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
Demetris, AJ; Miyazawa, H; Murase, N; Nakamura, K; Starzl, TE; Tanabe, M; Valdivia, LA | 1 |
Armitage, J; Fung, JJ; Jordan, M; McCauley, J; Nour, B; Reyes, J; Shapiro, R; Starzl, TE; Todo, S; Tzakis, AG | 1 |
Backman, L; Gibbs, JF; Goldstein, RM; Gonwa, TA; Holman, MJ; Husberg, BS; Klintmalm, GB; Levy, M; McMillan, R; Morris, C | 1 |
Ascher, NL; Goldstein, R; Gonwa, T; Klintmalm, GB; Krom, RA; Lake, J; Roberts, JW; Shaw, BW; Stratta, R; Wiesner, RH | 1 |
Beaver, S; Crotty, P; Gores, GJ; Hay, JE; Krom, RA; Porayko, MK; Richards, T; Sanchez-Urdazpal, L; Textor, SC; Wahlstrom, HE | 1 |
Demetris, AJ; Fung, JJ; Irish, WD; Jensen, C; Jordan, ML; McCauley, J; Mitchell, S; Scantlebury, VP; Shapiro, R; Vivas, C | 1 |
Crippin, J; Goldstein, R; Gonwa, TA; Holman, M; Husberg, B; Klintmalm, G; Stephens, J | 1 |
Jensen, C; Jordan, M; McCauley, J; Scantlebury, V; Shapiro, R; Starzl, TE; Vivas, C | 1 |
Gores, GJ; Hay, JE; Kamath, PS; Krom, RA; Porayko, MK; Wahlstrom, HE; Wiesner, RH | 1 |
Backman, L; Gibbs, JF; Goldstein, RM; Gonwa, TA; Holman, MJ; Husberg, BS; Klintmalm, GB; Levy, M; McMillan, R | 1 |
Jendrisak, MD; Marsh, JW; Perdrizet, GA; So, S; White, HM; Woodle, ES | 3 |
Carroll, P; Fung, JJ; Jordan, M; McCauley, J; Odocha, O; Scantlebury, V; Shapiro, R; Starzl, TE; Vivas, C | 2 |
Bechstein, WO; Blumhardt, G; Dé, P; Lange, D; Neuhaus, P; Schattenfroh, N | 1 |
Buckels, J; Cramb, R; Dousset, B; Krentz, AJ; Mayer, D; McMaster, P; Nattrass, M; Smith, JM | 1 |
Asshinnik, A; Basadonna, G; Colquhoun, S; Perez, R; Rubin, M; Swanson, C | 1 |
Bechstein, WO; Blumhardt, G; Jonas, S; Kling, N; Lobeck, H; Lohmann, R; Neuhaus, P | 1 |
Canafax, DM; Lake, KD | 1 |
Burke, G; Ciancio, G; Esquenazi, V; Loreto-Grand, B; Luque, C; Miller, J; Rosen, A; Siquijor, A | 1 |
Demetris, AJ; Griffith, BP; Hattler, BG; Kawai, A; Kormos, RL; Murali, S; Pham, SM | 1 |
Conway, P; Madras, PN; Monaco, AP; Shaffer, D; Simpson, MA; Washburn, WK | 1 |
Akiyama, T; Amemiya, H; Fukunishi, T; Hanafusa, T; Ichikawa, Y; Ihara, H; Ito, K; Kokado, Y; Kurita, T; Kyo, M; Nagano, S; Okuyama, A; Sagawa, S; Sonoda, T; Suzuki, S; Takahara, S | 1 |
Alloway, RR; Amiri, MH; Gaber, AO; Gaber, LW; Russell, WC; Vera, SR | 1 |
Bruce, DS; Charette, JI; Haas, M; Josephson, MA; Millis, JM; Newell, KA; Piper, JB; Thistlethwaite, JR; Woodle, ES | 1 |
Hashimoto, T; Itoh, K; Manabe, T; Nakamura, Y; Otobe, Y; Satoh, M; Shimizu, Y; Suzuki, T; Tanaka, M; Ueda, N | 1 |
Bridges, ND; Canter, CE; Huddleston, CB; Mallory, GB; Spray, TL | 1 |
Busuttil, RW; Cecka, M; Dawson, S; Imagawa, DK; Johnson, C; Shackleton, CR; Terasaki, PI | 1 |
Aweeka, FT; Tsunoda, SM | 1 |
Franco, P; Galmarini, D; Gatti, S; Marelli, O; Orsenigo, R; Perego, C; Reggiani, P; Rossi, G | 1 |
Colledan, M; Di Mauro, P; Doglia, M; Fassati, LR; Franco, P; Galmarini, D; Gatti, S; Gridelli, B; Maggi, U; Marelli, O; Orsenigo, R; Perego, C; Quarenghi, E; Reggiani, P; Rossi, G | 1 |
Klassen, J; Scott-Douglas, N; Zimmerman, D | 1 |
Behrend, M; Brunkhorst, R; Eberhard, OK; Kliem, V; Koch, KM; Oldhafer, K; Pichlmayr, R; Schaumann, D; Schlitt, HJ | 1 |
Becker, G; Friedrich, J; Heemann, U; Philipp, T; Wagner, K; Witzke, O | 1 |
Armstrong, VW; Braun, F; Canelo, R; Christians, U; Grupp, C; Lorf, T; Oellerich, M; Ringe, B; Sattler, B; Schütz, E; Sewing, KF | 1 |
Manns, MP; Rambusch, EG | 1 |
Adams, EM; Villalba, L | 1 |
Demetris, AJ; Flynn, B; Fung, JJ; Irish, W; Marino, IR; Mazariegos, GV; McMichael, J; Reyes, J; Starzl, TE | 1 |
Codazzi, D; Fassati, LR; Galmarini, D; Gatti, S; Langer, M; Latham, L; Melada, E; Prato, P; Privitera, G; Reggiani, P; Romito, R; Rossi, G; Vannelli, A; Velio, P | 1 |
Bardella, MT; Fassati, LR; Gatti, S; Rossi, G; Velio, P | 1 |
Case, B; Colombani, P; Fivush, B; McKee, M; Neu, A; Segev, D; Wise, B | 1 |
Alonso, EM; Kelly, SM; Newell, KA; Rubin, CM; Thistlethwaite, JR; Whitington, PF | 1 |
Aronson, AJ; Bartosh, S; Bruce, DS; Haas, M; Josephson, MA; Millis, JM; Newell, KA; Piper, JB; Thistlethwaite, JR; Woodle, ES | 1 |
Gruessner, RW | 1 |
Engler, S; Otto, G; Rudi, J; Stremmel, W; Theilmann, L | 1 |
Sayegh, MH; Vella, JP | 1 |
Burke, GW; Ciancio, G; Miller, J; Roth, D; Xenos, EX | 1 |
Hatori, M; Honda, M; Ichimaru, N; Imai, E; Kokado, Y; Kyo, M; Matsumiya, K; Miyamoto, M; Nonomura, N; Okuyama, A; Takahara, S; Takao, T; Yokoyama, K | 1 |
Alfrey, EJ; Dafoe, DC; Krieger, NR; Lee, CM; Scandling, JD | 1 |
Aradhye, S; Arenas, J; Barker, C; Brayman, KL; Deng, S; Grossman, R; Naji, A; Shaw, L; Weber, M | 1 |
Dunn, DL; Gruessner, AC; Gruessner, RW; Najarian, JS; Sutherland, DE | 1 |
Hamashima, T; Mizuta, N; Nakai, I; Nakajima, H; Nakamura, K; Ohmori, Y; Oka, T; Okamoto, M; Yasumura, T; Yoshimura, N | 1 |
Bueno, J; Finn, L; Reyes, J; Yunis, E | 1 |
Behrend, M; Bramlage, C; Brunkhorst, R; Kliem, V; Koch, KM; Meiners, M; Pichlmayr, R; Radermacher, J; Schlitt, HJ | 1 |
Azoulay, D; Bismuth, H; Debuire, B; Frenoy, N; Lemoine, A; Pham, H; Reynès, M; Salvucci, M; Samuel, D | 1 |
Akizuki, E; Ichiguchi, O; Liang, J; Matsuda, T; Matsumura, F; Mori, K; Ogawa, M; Ohshiro, H; Okabe, K; Yamada, S; Yamaguchi, Y | 1 |
Büsing, M; Heimes, M; Klempnauer, J; Kozuschek, W; Martin, D; Schulz, T | 1 |
Meiser, BM; Pehlivanli, S; Schulze, C; Uberfuhr, P; von Scheidt, W; Weis, M; Wildhirt, SM | 1 |
McCune, WJ; Singer, NG | 1 |
Coles, JG; McCrindle, BW; Walker, RE; West, LJ | 1 |
Banner, N; Burke, M; Khaghani, A; Marcus, N; Yacoub, M | 1 |
Budde, K; Fritsche, L; Giessing, M; Morgera, S; Neumayer, HH; Schröder, K; Sperschneider, H; Stein, G | 1 |
Jensik, SC | 1 |
Katagiri, A; Nakagawa, Y; Saito, K; Sonda, K; Takahashi, K; Takeda, M; Tanigawa, T; Tomita, Y | 1 |
Fuchinoue, S; Ishikawa, N; Kanematsu, A; Kitani, R; Oshima, T; Takahashi, K; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Balaji, V; Jurewicz, WA; Lord, R; Moore, R; Morris-Stiff, G; Ostrowski, K; Singh, J; Webley, Y | 1 |
Bruce, DS; Cronin, DC; Davis, B; Grewal, H; Loss, GE; Millis, JM; Newell, KA; Siegel, C; Thistlethwaite, JR; Todo, T; Turner, CD; Woodle, ES | 1 |
Ernst, W; Feuring, E; Friemann, S; Padberg, W | 1 |
Brunkhorst, R; Ehlerding, G; Eisenberger, U; Kliem, V; Koch, KM; Petersen, R; Pichlmayr, R; Schaumann, D | 1 |
Demetris, AJ; Fung, JJ; Gritsch, HA; Jordan, ML; McCauley, J; McMichael, J; Naraghi, R; Randhawa, P; Scantlebury, VP; Shapiro, R; Smith, D; Starzl, TE; Vivas, CA | 1 |
Ader, JL; Cisterne, JM; Durand, D; Rostaing, L; Tack, I; Tran-Van, T | 2 |
Mendez, R | 1 |
Behrend, M; Buchholz, B; Claesson, K; Eigler, FW; Ericzon, BG; Forsythe, JL; Grabensee, B; Johnson, RW; Land, W; Mayer, AD; Morales, JM; Mühlbacher, F; Neumayer, HH; Squifflet, JP; van Hooff, J; Vanrenterghem, Y | 1 |
Fung, JJ; Gritsch, HA; Hakala, TR; Irish, W; Jordan, ML; McCauley, J; McMichael, J; McQuitty, D; Randhawa, P; Scantlebury, VP; Shapiro, R; Simmons, RL; Starzl, TE; Vivas, C | 1 |
Caccamo, L; Doglia, M; Fassati, LR; Galmarini, D; Gatti, S; Leoni, L; Maggi, U; Orsenigo, R; Paone, G; Reggiani, P; Rossi, G | 1 |
Baldini, E; Baulieux, J; Belghiti, J; Bismuth, H; Boillot, O; Calmus, Y; Campan, P; Cherqui, D; Domergue, J; Ducerf, C; Durand, F; Duvoux, C; Ellero, E; Gugenheim, J; Launois, B; LeTreut, Y; Massault, PP; Messner, M; Neau-Cransac, M; Pageaux, J; Samuel, D; Saric, J; Wolf, P | 1 |
Chapman, W; Geevarghese, S; Helderman, JH; MacDonell, R; Payne, J; Pinson, CW; Richie, R; Van Buren, D; Wright, JK | 2 |
Lobeck, H; Mueller, AR; Neuhaus, P; Platz, KP; Zytowski, M | 1 |
Adham, M; Aljuaid, N; Baulieux, J; Berthoux, N; Bizollon, T; Chevallier, M; Delaroche, E; Ducerf, C; Taibi, A | 1 |
Bechstein, WO; Gebhard, A; Klupp, J; Langrehr, JM; Lobeck, H; Neuhaus, P; Neuhaus, R; Pratschke, J; Tullius, SG | 1 |
Arnout, W; Busuttil, RW; Colquhoun, S; Drazan, K; Farmer, DG; Ghobrial, RM; Goldstein, LI; Goss, J; Hollis, P; Holt, CD; Imagawa, D; Markman, JF; Markowitz, J; Martin, P; Pakrasi, A; Ponthieux, S; Rosen, H; Seu, P; Shackleton, CR; Singer, J; Stribling, R; Yersiz, H | 1 |
Agishi, T; Fuchinoue, S; Fujita, S; Hoshino, T; Kitajima, K; Nakajima, I; Nakamura, M; Sageshima, J; Sato, S; Sawada, T; Tanaka, K; Tojinbara, T | 1 |
Edelman, J; Kotloff, RM; Lipson, DA; Palevsky, HI | 1 |
Cremer, J; Franke, U; Harringer, W; Haverich, A; Korff, F; Krug, N; Strüber, M; Wahlers, T; Wiebe, K | 1 |
Stratta, RJ | 1 |
Drangstveit, MB; Gruessner, AC; Gruessner, RW; Humar, A; Sutherland, DE; Wrenshall, L | 1 |
Alberti, D; Caccia, G; de Ville de Goyet, J; Falchetti, D; Otte, JB; Reding, R; Rigamonti, W; Sokal, E | 1 |
Actis, GC; Ciancio, A; Lagget, M; Leone, N; Marzano, A; Rizzetto, M; Salizzoni, M | 1 |
Bechstein, WO; Frei, U; Kahl, A; Lang, M; Neuhaus, P; Neumann, U; Settmacher, U | 1 |
Angermann, CE; Behr, TM; Feucht, H; Fischer, P; Meiser, B; Pongratz, D; Reichart, B; Richter, K; Spes, CH; Theisen, K | 1 |
Donadio, C; Giordani, R; Lucchesi, A; Puccini, R; Rizzo, G | 1 |
Brunton, C; Burns, A; Davenport, A; Fernando, ON; Fernando, RL; Moorhead, JF; Powis, SH; Psimenou, E; Sweny, P; Turakhia, G; Varghese, Z | 1 |
Bechstein, WO; Berg, T; Guckelberger, O; Hopf, U; Jonas, S; Müller, AR; Neuhaus, P; Platz, KP; Settmacher, U; Steinmüller, T; Tullius, SG | 1 |
Böhler, T; Budde, K; Fritsche, L; Giessing, M; Neumayer, HH; Schröder, K; Sperschneider, H; Stein, G; Türk, H | 1 |
Binder, L; Braun, F; Grupp, C; Hanack, U; Lorf, T; Müller, GA; Ringe, B; Sattler, B | 1 |
Horning, NR; Lynch, JP; Patterson, GA; Sundaresan, SR; Trulock, EP | 1 |
Cobalti, B; Doglia, M; Fassati, LR; Galmarini, D; Gatti, S; Ghidoni, P; Latham, L; Rossi, G | 1 |
Antoine, C; Boudjeltia, S; Daugas, E; Fraoui, R; Glotz, D; Julia, P; Nochy, D; Thakur, S | 1 |
Armenti, VT; Davison, JM; Moritz, MJ | 1 |
Boulland, ML; Calmus, Y; Chereau, C; Conti, F; Dousset, B; Leroy-Viard, K; Soubrane, O; Weill, B | 1 |
Chen, YS; Chou, NK; Chu, SH; Hsu, RB; Ko, WJ; Wang, SS | 1 |
Chan, KL; Fan, ST; Fung, SK; Lai, CL; Lau, GK; Liu, CL; Lo, CM; Ng, IO; Wong, J | 1 |
Chen, MF; Hsieh, CH; Hung, CM; Jeng, LB; Lee, WC; Yeh, CN | 1 |
Chak, WL; Chan, YH; Chau, KF; Cheng, HM; Cheng, YL; Choi, KS; Li, CS; Wong, FK | 1 |
Goh, BL; Tan, SY | 1 |
Andreani, P; Caccamo, L; Fassati, LR; Gatti, S; Latham, L; Maggi, U; Melada, E; Paone, G; Reggiani, P; Rossi, G; Vannelli, A | 1 |
Opelz, G | 1 |
Detry, O; Honoré, P; Jacquet, N; Meurisse, M | 1 |
Anderson, V; Baqi, N; Hidalgo, G; Kumar, A; Markell, MS; Piecuch, S; Singh, A; Vyas, S | 1 |
Corry, RJ; Egidi, F; Fung, JJ; Gritsch, HA; Jordan, ML; Khanna, A; Scantlebury, VP; Shapiro, R; Starzl, TE; Vivas, CA | 1 |
Ellis, D; Fung, JJ; Gilboa, N; Gritsch, HA; Hakala, TR; Irish, W; Jordan, ML; Lombardozzi-Lane, S; McCauley, J; Scantlebury, VP; Shapiro, R; Simmons, RL; Starzl, TE; Vivas, C | 1 |
Bartholomew, AM; Benedetti, E; Coady, N; Dunn, TB; Holman, DM; Pollak, R; Raofi, V; Vazquez, E | 1 |
Briegel, J; Deutsch, O; Fürst, H; Kur, F; Meiser, BM; Müller, C; Reichart, B; Reichenspurner, H; Schwaiblmair, M; Treede, H; Vogelmeier, C; Welz, A | 1 |
Kaplan, HJ; Van Gelder, RN | 1 |
Alvárez-Cienfuegos, J; Girala, M; Gómez-Manero, N; Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Sangro, B | 1 |
Alvarez, ML; Ballester, B; Errasti, P; García, I; García, N; Gómez, G; Lavilla, FJ; Purroy, A | 1 |
Alonso, A; García Meseguer, C; Martinez Débora, MJ; Navarro, M; Vanegas, JJ | 1 |
Katsumata, S; Miyaoka, M; Saito, T; Shiratori, T | 1 |
Christiaans, MH; van Duijnhoven, EM; van Hooff, JP | 1 |
Aljama, P; Del Castillo, D; Holgado, R; Pérez, R; Soriano, S | 1 |
Jurewicz, WA | 1 |
Agishi, T; Fuchinoue, S; Ishida, H; Kimikawa, M; Koyama, I; Nakajima, I; Nakamura, M; Sannomiya, A; Sato, S; Tanabe, K; Tojimbara, T; Tsuji, K; Utsumi, K | 1 |
Fuchinoue, S; Harano, M; Inui, M; Ishikawa, N; Kanematsu, A; Manu, MA; Oshima, T; Otsubo, S; Shinmura, H; Tanabe, K; Tokumoto, T; Toma, H | 1 |
Hamajima, T; Najima, H; Nakai, I; Oka, T; Okamoto, M; Ushigome, H; Yoshimura, N | 1 |
Bush, WW | 1 |
Lowry, PW; Sandborn, WJ; Tremaine, WJ; Weaver, AL | 1 |
Ghoos, Y; Kuypers, D; Maes, BD; Rutgeerts, PJ; Vanrenterghem, YF; Vanwalleghem, J | 1 |
Binet, I; Dickenmann, MJ; Steiger, J; Tamm, M; Thiel, G; Tsinalis, D | 1 |
Deol, HS; Tuch, BE; Wright, DC | 1 |
Barrou, B; Benalia, H; Bitker, MO; Chatelain, C; Grimaldi, A; Mouquet, C; Ourahma, S; Richard, F | 1 |
Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield, C; Sorensen, J; Stegall, M; Tolzman, D; van Veldhuisen, P; Wachs, M | 1 |
Jensik, SC; Mendez, R; Miller, J; Pirsch, JD | 1 |
Malinowski, K; Waltzer, WC; Ye, H | 1 |
Bechstein, WO; Gebhardt, A; Klupp, J; Langrehr, JM; Lohmann, R; Neuhaus, P; Neuhaus, R; Neumann, U; Pratschke, J; Radke, C; Rayes, N; Tullius, SG | 1 |
Andrés, A; Campistol, JM; Herrero, JC; Morales, JM | 1 |
Flores, F; Kerdel, FA | 1 |
Iwadare, JI; Komeno, Y; Kondo, K; Matsuhashi, N; Muto, T; Nagawa, H; Nakajima, A; Ohnishi, S; Omata, M; Suzuki, A; Usui, Y; Watanabe, K; Watanabe, T | 1 |
Bento, C; Ferrão, J; Furtado, A; Furtado, E; Geraldes, B; Mota, O; Neves, S; Oliveira, F; Perdigoto, R; Tomé, L; Viana, J; Vieira, H | 1 |
Balint, JP; Bousvaros, A; Daum, F; Day, AS; Ferry, GD; Freeman, KB; Griffiths, AM; Kirschner, BS; Leichtner, AM; Parker-Hartigan, L; Werlin, SL; Zurakowski, D | 1 |
Lye, WC | 1 |
Liming, W; Youhua, Z; Zhinlian, M | 1 |
Cheng, XJ; Fu, SJ; Wang, Y; Yu, L | 1 |
Han, DJ; Jang, HJ; Kim, SC | 1 |
Nakai, I; Nakajima, H; Ohmori, Y; Oka, T; Okamoto, M; Sakaguchi, K; Sugioka, N; Ushigome, H; Yoshimura, N; Yoshimura, R | 1 |
Chak, WL; Chan, YH; Chau, KF; Cheung, CY; Choi, KS; Li, CS; Wong, KM | 1 |
Ishikawa, N; Ito, S; Koga, S; Tanabe, K; Toda, F; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Honda, K; Ishikawa, N; Nihei, H; Shimizu, T; Suzuki, K; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Fuchinoue, S; Harano, M; Ichikura, H; Inui, M; Ishikawa, N; Ito, S; Manu, M; Okuda, H; Shimmura, H; Shimuzu, T; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Fuchinoue, S; Harano, M; Inui, M; Ishikawa, N; Ito, S; Manu, M; Okuda, H; Shimizu, T; Shimmura, H; Shiroyanagi, Y; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Chan, HW; Lee, W; Tong, KL; Tsang, WK; Yeung, S | 1 |
Ishikawa, N; Oshima, T; Shimizu, T; Shimmura, H; Tanabe, K; Tokumoto, T; Toma, H; Yamaguchi, Y | 1 |
Dias, L; Guimaräes, S; Henriques, AC; Martins, L; Pereira, MC; Sarmento, AM | 1 |
Cristol, JP; Descomps, B; Dupuy, AM; Garrigue, V; Mourad, G; Tur, MD; Vela, C | 1 |
Catanzano, J; Cristol, JP; Descomps, B; Garrigue, V; Morena, M; Mourad, G; Vela, C | 1 |
Butani, L; Makker, SP | 1 |
Dassopoulos, T; Hanauer, SB | 1 |
Ohashi, H; Ohno, R | 1 |
Kahan, BD; Mahalati, K | 1 |
Armstrong, VW; Oellerich, M | 1 |
Bismuth, H; Calne, R; Devlin, J; Groth, C; McMaster, P; Neuhaus, P; Otto, G; Pichlmayr, R; Williams, R | 1 |
Ishii, T; Kai, T; Kawano, K; Kim, YI; Kobayashi, M; Tatsuma, T | 1 |
Ayres, S; Buckels, JA; Buist, LJ; Dmitrewski, J; Gunson, BK; Mayer, AD; McMaster, P | 1 |
Guañabens, N; Martínez de Osaba, MJ; Monegal, A; Muñoz-Gómez, J; Navasa, M; Peris, P; Pons, F; Rimola, A; Rodés, J | 1 |
Fung, JJ; Jain, A; Kashyap, R; Khanna, A; Marsh, W; Rohal, S | 1 |
Fathi, M; Gerbase, MW; Nicod, LP; Spiliopoulos, A | 1 |
Castagneto, M; Cavallari, A; Cillo, U; Fassati, LR; Filipponi, F; Forti, D; Gerunda, GE; Risaliti, A; Salizzoni, M; Tisone, G; Valente, U | 1 |
Bechstein, WO; Jonas, S; Klupp, J; Langrehr, JM; Lohmann, R; Neuhaus, P; Neuhaus, R; Raakow, R | 1 |
Kaplan, E; Katz, P; Merhav, H; Nakache, R; Weinbroum, A | 1 |
Meisterling, LD; Schweizer, RT | 1 |
Bechstein, WO; Jonas, S; Junge, G; Klupp, J; Langrehr, JM; Neuhaus, P; Neuhaus, R | 1 |
Burdick, JF; Koyama, I; Kyo, S; Nagashima, N; Ogawa, N; Shalabi, A; Watanabe, T | 1 |
Campana, C; Iacona, I; Molinaro, M; Pasquino, S; Regazzi, MB; Rinaldi, M; Viganò, M | 1 |
Baulieux, J; Belghiti, J; Boillot, O; Calmus, Y; Cherqui, D; Gugenheim, J; Le Treut, Y; Messner, M; Neau-Cransac, M; Pageaux, G; Samuel, D; Wolf, P | 1 |
Charpentier, B | 1 |
Weir, MR | 1 |
Ahsan, N; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Light, J; Metzger, R; Mulloy, L; Rocher, L; Salm, K; Scandling, J; Shield , C; Sorensen, J; Stegall, M; Tolzman, D; VanVeldhuisen, P; Wachs, M | 1 |
Andries, S; Bernard Otte, J; Burlet, M; Buts, JP; Casamayou, L; Reding, R; Sempoux, C; Sokal, E | 1 |
Barron, J; Johnson, D; Kwan, JT; McCloskey, E; McGee, G; Ogunremi, L; Patel, S; Thomas, G; Wills, R | 1 |
Kanda, H; Kubo, K; Mimura, T | 1 |
Holtmeier, J; Leuschner, U | 1 |
Barenbrock, M; Hausberg, M; Kisters, K; Kosch, M; Rahn, KH | 1 |
Berg, U; Ingelman-Sundberg, M; Lytton, SD; Nemeth, A | 1 |
Margreiter, R | 1 |
Ortuño, J; Pascual, J | 1 |
Albiol, MT; Busquets, J; Fabregat, J; Figueras, J; Ibáñez, L; Jaurrieta, E; Lama, C; Lladó, L; Rafecas, A; Ramos, E; Torras, J | 1 |
Busquets, J; Fabregat, J; Figueras, J; Ibáñez, L; Jaurrieta, E; Lama, C; Lladó, L; Rafecas, A; Ramos, E; Torras, J | 1 |
Araujo, G; Ferrer, J; Parisi, C; Romeo, L; Sgrosso, JL; Vázquez, MC | 1 |
Harringer, W; Haverich, A; Pichlmaier, MA; Strüber, M; Teebken, OE | 1 |
Baliellas, C; Fabregat, J; Figueras, J; Ibañez, L; Jaurrieta, E; Lama, C; Lladó, L; Rafecas, A; Ramos, E; Torras, J | 1 |
Arias, M; Krämer, BK; Montagnino, G | 1 |
Garcia, I | 1 |
Abbud Filho, M; Campos, HH | 1 |
Forsythe, JL; Oniscu, GC; Wayman, MR; Whitworth, CE | 1 |
Akioka, K; Kadotani, Y; Nakamura, K; Ohmori, Y; Okamoto, M; Ushigome, H; Yoshimura, N | 1 |
Hansen, HE; Heinsvig, EM; Jørgensen, KA; Madsen, M; Madsen, S; Pedersen, AR; Poulsen, JH; Povlsen, JV | 1 |
Bechstein, WO; Dette, K; Lübke, P; Pridöhl, O; Woeste, G; Wullstein, C | 1 |
Abdelhalim, FM; Baron, PW; Concepcion, W; Cutler, D; Hasan, SM; Ojogho, ON; Sahney, S | 1 |
Nishikawa, K; Terasaki, PI | 1 |
Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A | 1 |
Bernard, PH; Merville, P; Morel, D; Neau-Cransac, M; Potaux, L; Revel, P; Saric, J | 1 |
Altaca, G; Aydin, C; Berber, I; Titiz, I | 1 |
Daniel, V; Dietrich, H; Ernst, W; Feustel, A; Friemann, S; Grimm, H; Heilke, M; Li, D; Opelz, G; Padberg, W; Rainer, L; Staak, A; Streller, S; Weimer, R; Zimmermann, T; Zinn, S | 1 |
Czaja, AJ | 1 |
Alsina, J; Fiol, C; Gil-Vernet, S; Gómez-Gerique, N; Grinyó, JM; Hurtado, I; Martínez Castelao, A; Ramos, R; Sabaté, I; Serón, D; Yzaguirre, MT | 1 |
Asztalos, L; Bachleda, P; Hickey, D; Klinger, M; Kokot, F; Nagy, KK; Navratil, P; Ostrowski, M; Perner, F; Rutkowski, B; Studenik, P; Szenohradsky, P; Vitko, S; Wałaszewski, J; Włodarczyk, Z | 1 |
Bar, J; Hod, M; Merlob, P; Pardo, J; Stahl, B; Wittenberg, C | 1 |
Aravot, D; Izbicki, G; Kramer, MR; Sahar, G; Saute, M; Shitrit, D; Sulkes, J | 1 |
Callaway, A; Pistorius, A; Willershausen, B | 1 |
Kushwaha, SS; Mayer, DF | 1 |
De Geest, S; Margodt, D; Moons, P; Mullens, M; Squifflet, JP; Thevissen, I; Van Hooff, JP; Vanrenterghem, Y | 1 |
Fine, RN; Fivush, BA; Furth, SL; Ho, PL; Neu, AM | 1 |
Aerts, R; Fevery, J; Koshiba, T; Lauwers, P; Nevens, F; Pirenne, J; Roskams, T; Schetz, M; Van Gelder, F; Verhaegen, M | 1 |
Hídvégi, M; Járay, J; Langer, RM; Perner, F; Tóth, A; Végsö, G | 1 |
Ahsan, N; Alfrey, EJ; Corwin, C; Danovitch, G; Fitzsimmons, WE; Gonwa, T; Halloran, P; Hardy, M; Johnson, C; Leonhardt, M; Light, J; Metzger, R; Mulloy, L; Rocher, L; Scandling, J; Shield, C; Sorensen, J; Stegall, M; VanVeldhuisen, P; Wachs, M | 1 |
Pariente, A | 1 |
Dijkstra, G; Haagsma, EB; Kleibeuker, JH; Slooff, MJ; Van Den Berg, AP | 1 |
Al-Uzri, A; Kling, PJ; Yorgin, PD | 1 |
Bleyer, AJ; Cherikh, WS; Johnson, CP; Maghirang, J; Myron Kauffman, H | 1 |
Arias, M; Capdevila, L; del Castillo, D; Garcia, J; Gonzalez Molina, M; Ortuño, J; Pascual, J; Segoloni, G | 1 |
Arizón del Prado, JM; Aumente Rubio, MD; Cárdenas Aranzana, M; López Granados, A; López Malo de Molina, MD; Mesa Rubio, D; Rodriguez Esteban, E; Romo Peñas, E; Segura Saint-Gerons, C; Segura Saint-Gerons, J | 1 |
Alonso-Pulpón, L; Arroyo, R; Burgos, R; Fuertes, B; Moñivas, V; Ortiz, P; Peraira, JR; Segovia, J | 1 |
Durlik, M; Foroncewicz, B; Gradowska, L; Krawczyk, A; Lewandowska, D; Mucha, K; Nazarewski, S; Paczek, L; Pazik, J; Pliszczynski, J; Szmidt, J; Walaszewski, J | 1 |
Braun, WE | 1 |
Múzes, G | 1 |
Ak, K; Akgun, S; Arsan, S; Civelek, A; Isbir, SC; Kurtkaya, O; Sav, A; Tekeli, A | 1 |
Pleyer, U | 1 |
Escario, JA; Gómez-Barrio, A; Martínez-Fernández, AR; Nogal-Ruiz, JJ | 1 |
Gill, JS; Johnson, N; Mix, CH; Pereira, BJ; Tonelli, M | 1 |
Azzola, A; Black, J; Chhajed, P; Glanville, A; Havryk, A; Hostettler, K; Johnson, P; Roth, M; Tamm, M | 1 |
Antikainen, M; Hedman, M; Holmberg, C; Neuvonen, M; Neuvonen, PJ | 1 |
Ellis, JS; Seymour, RA; Taylor, JJ; Thomason, JM | 1 |
Rosenkrantz, WS | 1 |
Arora-Gupta, N; Davies, P; Kelly, DA; McKiernan, P | 1 |
Aubert, JD; Auterith, A; Böttcher, H; Chaparro, C; Corris, P; Estenne, M; Gerbase, MW; Glanville, A; Klepetko, W; Knoop, C; Levvey, B; Niedermayer, J; Reichenspurner, H; Sarahrudi, K; Venuta, F; Verleden, G | 1 |
Shapiro, R | 1 |
Bismuth, J; Canet, S; Chong, G; Garrigue, V; Lesnik, A; Mourad, G; Taourel, P | 1 |
Lang-Lazdunski, L | 1 |
Encke, J; Sauer, P; Stremmel, W; Uhl, W | 1 |
Lo, A | 1 |
Aqel, BA; Dickson, RC; Harnois, DM; Machicao, V; Rosser, B; Satyanarayana, R | 1 |
Kari, JA; Trompeter, RS | 1 |
McDonald, RA; Nemeth, TL; Smith, JM | 1 |
Takeda, Y; Tomino, Y | 1 |
Ito, N; Kamoto, T; Kinoshita, H; Nagahama, K; Nakamura, E; Ogawa, O; Okuno, H; Yamamoto, S; Yoshida, H | 1 |
Herrlinger, K; Stange, EF | 1 |
Heath, M; Raugi, GJ | 1 |
Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M | 1 |
Bermejo, J; Bouza, E; Carbone, J; Catalan, P; Fernández-Cruz, E; Fernàndez-Yáñez, J; Muñoz, P; Palomo, J; Rodríguez-Molina, JJ; Sarmiento, E | 1 |
Jonas, S; Junge, G; Klupp, J; Langrehr, JM; Neuhaus, P; Neuhaus, R; Settmacher, U; Theruvat, T | 1 |
Emre, SH; Rumbo, C; Shneider, BL | 1 |
Kobashigawa, J; Lindenfeld, J; Lowes, BD; Mestroni, L; Miller, GG; Page, RL; Shakar, SF; Wolfel, EE; Zolty, R | 1 |
Dirks, NL; Huth, B; Meibohm, B; Yates, CR | 1 |
Kunicki, PK; Sobieszczańska-Małek, M | 1 |
Baczkowska, T; Durlik, M | 1 |
Asztalos, L; Bachleda, P; Hickey, D; Kalmar, KN; Klinger, M; Kokot, F; Navratil, P; Ostrowski, M; Perner, F; Rutkowski, B; Studenik, P; Szenohradszky, P; Vitko, S; Walaszewski, J; Wlodarczyk, Z | 1 |
Atasever, A; Bacakoglu, F; Basak, K; Basoglu, OK; Duman, S; Guzelant, A; Sayiner, A; Toz, H | 1 |
Brandrup-Wognsen, G; Costard-Jäckle, A; Crespo-Leiro, MG; Duveau, D; Gronda, E; Harringer, W; Haverich, A; Karason, K; Khazen, CS; Laufer, G; Mangiavacchi, M; Mattei, MF; Podesser, BK; Pulpón, LA; Rinaldi, M; Segovia, J; Treilhaud, M; Viganó, M; Villemot, JP; Yona, NA | 1 |
Lebranchu, Y; Mornex, JF; Sirinelli, A; Wolf, P | 1 |
Albert, ED; Banas, B; Friedrich, N; Lederer, SR; Sitter, T; Welser, G | 1 |
Bij, W; Kauffman, HF; Koëter, GH; Postma, DS; Slebos, DJ; Verschuuren, EA | 1 |
Burroughs, AK; Davidson, BR; Davies, S; Dhillon, AP; Emery, V; Griffiths, P; Leandro, G; Papatheodoridis, GV; Patch, DW; Quaglia, A; Rolando, N; Rolles, K; Sabin, CA; Samonakis, DN; Teixeira, R; Thalheimer, U; Triantos, CK | 1 |
González, MG; Gutiérrez, MG; Herrero, JI; Madrazo, CP; Ortiz de Urbina, J; Pallardó, JM; Paricio, PP; Rodríguez, AB | 1 |
Akiyama, Y; Aramaki, O; Ikeda, Y; Inoue, F; Kitajima, M; Matsumoto, K; Niimi, M; Shibutani, S; Shimazu, M; Shirasugi, N | 1 |
Date, H; Shimizu, N | 1 |
Cantarell, C; Gentil, MA; González-Roncero, F; López, M; Marco, J | 1 |
Hibi, T; Hisamatsu, T | 1 |
Abu-Elmagd, K; Bond, GJ; Macedo, C; Mazariegos, GV; Murase, N; Peters, J; Reyes, J; Sindhi, R; Starzl, TE | 1 |
Jørgensen, KA; Karamperis, N; Koefoed-Nielsen, PB | 1 |
Matsui, T | 1 |
Benedetti, E; Briars, L; John, E; Knight, PS; Kraft, KA; Lumpaopong, A; Oberholzer, J; Sankary, HN; Testa, G; Verghese, P | 1 |
Balzar, E; Brekke, IB; Filler, G; Friman, S; Gellermann, J; Grenda, R; Griebel, M; Hughes, D; McGraw, M; Milford, DV; Offner, G; Trompeter, R; Tyden, G; Vondrak, K; Watson, AR; Webb, NJ | 1 |
Meyrier, A | 1 |
Lin, PT; Martin, BA; So, YT; Weinacker, AB | 1 |
Ciancio, G; Gonwa, TA; Miller, J | 1 |
Buell, JF; Gross, TG; Woodle, ES | 1 |
Triemer, H | 1 |
Habuchi, T; Horikawa, Y; Inoue, T; Kakinuma, H; Matsuura, S; Numakura, K; Saito, M; Satoh, S; Suzuki, T; Tada, H; Tsuchiya, N | 1 |
Gryboś, M; Kazimierczak, I; Kazimierczak, K; Klinger, M; Weyde, W; Zmonarski, S | 1 |
Felipe, CR; Franco, M; Garcia, R; Medina-Pestana, J; Moreira, SR; Park, SI; Pinheiro-Machado, P; Silva, LA; Tedesco-Silva, H | 1 |
Barrou, B; Kornprobst, M; Nicolas, JC; Rampini, C | 1 |
Baumgart, DC; Dignass, AU; Pintoffl, JP; Sturm, A; Wiedenmann, B | 1 |
Burroughs, AK; Davidson, BR; Dhillon, AP; Leandro, G; Mela, M; Patch, DW; Pesci, A; Quaglia, A; Raimondo, ML; Rolles, K; Samonakis, DN; Thalheimer, U; Triantos, CK | 1 |
Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
Bell, L; Burns, A; Hamiwka, LA | 1 |
Cheng, Y; Cherikh, WS; Hanto, DW; Kauffman, HM; McBride, MA | 1 |
Morelon, E; Thaunat, O | 1 |
Berland, Y; Bonnet, E; Brunet, C; George, FD; Loundou, A; Lyonnet, L; Moal, V; Paul, P; Ravet, S; Sampol, J; Sampol-Manos, E; Vacher-Coponat, H | 1 |
Deel, C; Hellman, RN; Khan, BA | 1 |
Kästner, U; Kuhn, A; Kuhn, C; Markau, S; Osten, B | 1 |
Arbustini, E; Bini, F; Fietta, AM; Meloni, F; Morosini, M; Pellegrini, C; Solari, N; Vitulo, P | 1 |
Dietrich, H; Ernst, W; Kamali-Ernst, S; Opelz, G; Padberg, W; Rainer, L; Renner, F; Staak, A; Suesal, C; Weimer, R | 1 |
Murray, KF | 1 |
Stockfleth, E; Ulrich, C | 1 |
Bryan, CF; Murillo, D; Nelson, PW; Shield, CF; Wakefield, MR; Warady, BA; Winklhofer, FT | 1 |
Ichimaru, N; Imamura, R; Imao, T; Isaka, Y; Kokado, Y; Namba, Y; Nonomura, N; Okumi, M; Okuyama, A; Takahara, S | 1 |
Lotufo, RF; Paixão, CG; Pannuti, CM; Romito, GA; Saraiva, L; Sekiguchi, RT | 1 |
Agarwal, SK; Bhowmik, D; Chatterjee, A; Chaudhary, A; Dash, SC; Dinda, A; Guleria, S; Gupta, S; Kamboj, M; Mahajan, S; Sharma, M; Tiwari, SC | 1 |
Huang, WY | 1 |
Dick, AD; Hogan, AC; Lee, RW; McAvoy, CE | 1 |
Valantine, H | 1 |
Koutroubakis, IE | 1 |
Snell, GI; Westall, GP | 1 |
Baird, BC; Barenbaum, LL; Goldfarb-Rumyantzev, AS; Habib, AN; Lin, SJ; Shihab, FS; Smith, L | 1 |
Aloush, AA; Chakinala, MM; Hachem, RR; Lynch, JP; Meyers, BF; Patterson, GA; Trulock, EP; Yusen, RD | 1 |
Hart, IK; Sathasivam, S; Sharshar, T | 1 |
Járay, J; Végso, G | 1 |
Tada, M | 1 |
Almeida, JM; Ikeda, MY; Saber, LT | 1 |
Cezário, ES; Costa, FO; Cota, LO; Ferreira, SD; Siqueira, FM; Soares, RV; Zenóbio, EG | 1 |
Chak, WL; Chan, HW; Chan, YH; Chau, KF; Cheung, CY; Choi, KS; Li, CS; Liu, YL; Shek, CC; Wong, HS; Wong, KM | 1 |
Armstrong, VW; Brandhorst, G; Koerfer, R; Oellerich, M; Oezpeker, C; Tenderich, G; Zittermann, A | 1 |
Campbell, S; Chadban, SJ; Chang, SH; McDonald, SP; Russ, GR | 1 |
Anglicheau, D; Beaune, P; Legendre, C; Thervet, E | 1 |
Coser, PL; de los Santos, CA; Fortes, ME; Marroni, CA | 1 |
Bakr, MA; Baz, ME; Gheith, OA; Ghoneim, MA; Ismael, AM; Shehab El-Dein, AB | 1 |
Benedini, S; Luzi, L; Mancuso, M; Ruffini, E; Terruzzi, I | 1 |
Amagai, M; Nishikawa, T; Takae, Y | 1 |
Fitzpatrick, MM; Friman, S; Hamer, C; Hughes, DA; Janssen, F; Jones, CA; Marks, SD; Milford, DV; Moghal, NE; Prokurat, S; Rhodes, S; Saleem, MA; Van Damme-Lombaerts, R; Vondrak, K; Watson, AR; Webb, NJ | 1 |
El-Agroudy, AE; El-Baz, M; El-Dahshan, KF; Ghoneim, MA; Ismail, AM; Mahmoud, K; Shokeir, AA | 1 |
El-Agroudy, AE; El-Baz, M; El-Dahshan, K; Ghoneim, MA; Ismail, AM; Mahmoud, K; Shokeir, AA | 1 |
Cano, F; Cavada, G; Delucchi, A; Ferrario, M; Guerrero, JL; Lillo, AM; Rodríguez, E; Valenzuela, M | 1 |
El-Agroudy, AE; El-Baz, M; El-Dahshan, K; Ghoneim, MA; Mahmoud, K; Shokeir, AA | 1 |
Mimori, T | 1 |
Döhler, B; Opelz, G | 2 |
Baran, D; Birnbaum, LM; Cantarovich, M; Chaudhury, P; Herrera-Gayol, A; Lipman, M; Paraskevas, S; Tchervenkov, J | 1 |
Knoll, GA; Mulay, AV; van Walraven, C | 1 |
Friend, PJ; Reddy, S; Roberts, IS; Stratopoulos, C; Zilvetti, M | 1 |
Arcasoy, SM; Bacchetta, M; Celik, MR; D'Ovidio, F; Eser, D; Lederer, DJ; Sonett, JR; Wilt, J | 1 |
Kaplan, B; Schold, JD | 1 |
Altiparmak, MR; Apaydin, S; Seyahi, N; Tekgündüz, E | 1 |
Burroughs, AK; Cholongitas, E; Dhillon, AP; Hayes, P; Manousou, P; McCormick, A; O'Beirne, J; Patch, D; Rolles, K; Samonakis, D | 1 |
Bohl, DJ; Brennan, DC; Hardinger, KL; Koch, MJ; Storch, GA | 1 |
Chinnakotla, S; Goldstein, RM; Klintmalm, GB; Levy, MF; McKenna, GJ; Melton, LB; Onaca, N; Randall, HB; Ruiz, R; Sanchez, EQ | 1 |
Badiwala, M; Prodger, J; Ramzy, D; Raoa, V; Ross, H; Sheshgiri, R; Tepperman, E | 1 |
Yoshida, M | 1 |
Davaus Gasparetto, T; Marchiori, E; Menezes, P; Zanetti, G | 1 |
Dawwas, MF; Gimson, AE; Nash, KL; Sen, S | 1 |
Chambers, D; Hodge, G; Hodge, S; Holmes, M; Hopkins, P; Li-Liew, C; Reynolds, PN | 1 |
Angelico, M; Angelico, R; Brega, A; Di Paolo, D; Manzia, TM; Sforza, D; Tisone, G; Toti, L | 1 |
Fischer, L; Nashan, B; Schaefer, H; Staufer, K; Sterneck, M | 1 |
McFadden, JP; Wee, JS; White, IR; White, JM | 1 |
Bruckner-Tuderman, L; Büsing, V; Hofmann, SC; Kern, JS | 1 |
Bataille, S; Berland, Y; Dussol, B; Gaudart, J; Indreies, M; Moal, V; Purgus, R; Vacher-Coponat, H; Zandotti, C | 1 |
Adham, M; Boillot, O; Dumortier, J; Guillaud, O; Pittau, G; Salandre, J; Scoazec, JY | 1 |
Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; Deoliveira, NC; Durazo-Arvizu, R; Garrity, E; Husain, A; Krishnan, JA; Love, RB; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT | 1 |
Ahya, VN; Alex, CG; Arcasoy, SM; Bag, R; Baz, MA; Bhorade, S; Charbeneau, J; DeOliveira, NC; Durazo-Arvizu, R; Garrity, E; Krishnan, JA; Love, RB; McShane, PJ; Norwick, L; Seethamraju, H; Valentine, VG; Vigneswaran, WT | 1 |
Burgos, FJ; Fernández-Rodriguez, A; Galeano, C; Jiménez-Alvaro, S; Marcén, R; Quereda, C; Rivera, M; Teruel, JL | 1 |
Mitarai, T | 1 |
Bracamonte, ER; Lien, YH | 1 |
Steiner, RW | 1 |
Chiba, T; Inui, K; Masuda, S; Matsuura, M; Nakase, H; Yamamoto, S | 1 |
Bödeker, RH; Daniel, V; Deisz, S; Dietrich, H; Ernst, W; Kamali-Ernst, S; Opelz, G; Padberg, W; Renner, F; Weimer, R | 1 |
Mayo, MJ | 1 |
Bousvaros, A | 1 |
Fujikawa, T; Fujita, S; Hemming, AW; Kim, RD; Mizuno, S; Schwartz, JJ; Sorensen, JB | 1 |
Iida, S; Ishida, H; Miyamoto, N; Setoguchi, K; Shimizu, T; Shirakawa, H; Tanabe, K; Toki, D | 1 |
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
Andersson, P; Hindorf, U | 1 |
Felipe, CR; Medina-Pestana, JO; Ojopi, EB; Santoro, A; Struchiner, CJ; Suarez-Kurtz, G; Tedesco-Silva, H | 1 |
Yumura, W | 1 |
Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
Meier, J; Sturm, A | 1 |
Dankó, K; Vincze, M | 1 |
Frew, JW; Martin, LK; Murrell, DF | 1 |
Frew, JW; Murrell, DF | 1 |
Burroughs, AK; Germani, G; Samonakis, DN | 1 |
Ghoneim, MA; Ismail, AM; Kamal, AI; Mahmoud, KM; Refaie, AF; Sheashaa, HA | 1 |
Diago Almela, VJ; López Montes, J; Perales, A; Perales-Puchalt, A; Vila Vives, JM | 1 |
Niaudet, P | 1 |
Berland, Y; Brunet, P; Burtey, S; Daniel, L; Dussol, B; Indreies, M; Loundou, A; Moal, V; Moussi-Frances, J; Purgus, R; Vacher-Coponat, H | 1 |
Lee, EK; Mao, PC; Tseng, PL | 1 |
Cheng, CY; Shu, KH; Tsai, SF; Wu, MJ | 1 |
Alonso, EM; Ekong, UD; Mathew, J; Melin-Aldana, H; Wang, D | 1 |
Bootun, R | 1 |
Chen, J; Chen, W; Fu, J; Fu, P; Kong, Y; Li, Z; Liao, Y; Liu, F; Liu, Q; Liu, Z; Lou, T; Tang, X; Yang, Z; Yu, X; Zhang, J | 1 |
Graves, D; Vernino, S | 1 |
Dheerendra, PC; Jha, V; Kohli, HS; Kumar, V; Ramachandran, R; Rathi, M; Sakhuja, V | 1 |
Aggarwal, R; Oddis, CV | 1 |
Chan, AJ; Lake, JR | 1 |
Wagner, JA | 1 |
Yoshikawa, H | 1 |
Kane, SV; Yarur, A | 1 |
Cristelli, MP; Franco, MF; Medina-Pestana, JO; Tedesco-Silva, H | 1 |
Chmura, A; Ciszek, M; Durlik, M; Foroncewicz, B; Małkowski, P; Mucha, K; Pączek, L; Szmidt, J | 1 |
Hou, S | 1 |
Arakawa, T; Fujiwara, Y; Fukushima, W; Hagihara, Y; Hirota, Y; Kamata, N; Maeda, K; Ohfuji, S; Shiba, M; Sogawa, M; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H | 1 |
Burroughs, AK; Cholongitas, E; Corbani, A; Davidson, B; Davidson, J; Dhillon, AP; Hayes, P; Luong, T; Manousou, P; McCormick, PA; O'Beirne, J; Patch, D; Rodríguez-Perálvarez, M; Rolles, K; Samonakis, D; Thorburn, D; Tsochatzis, E | 1 |
Agena, F; Azevedo, LS; David-Neto, E; Gamba, C; Gerhard, J; Miraglia, JL; Pierrotti, L; Precioso, AR; Shikanai Yasuda, MA; Tavares Timenetsky, MD | 1 |
Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
Allen, J; Chadwick, PR; Green, D; Lamerton, E; Middleton, R; Mitsides, N; New, D; Redshaw, J; Subudhi, CP; Wood, G | 1 |
Berland, Y; Burtey, S; Dussol, B; Legris, T; Loundou, A; Moal, V; Picard, C; Purgus, R; Vacher-Coponat, H | 1 |
Chinnakotla, S; Dunn, TB; Gillingham, KJ; Matas, AJ; Mauer, MS; Verghese, PS | 1 |
Baghernejhad, M; Dastgheib, L; Sadati, MS | 1 |
Indriolo, A; Ravelli, P | 1 |
Buechter, M; Canbay, A; Gerken, G; Kahraman, A; Klein, CG; Kloeters, C; Schlaak, JF | 1 |
Godbold, J; Goldberg, NR; Jabs, DA; Lyu, T; Moshier, E | 1 |
Beyene, J; Brown, PE; Feldman, BM; Silverman, ED; Tian, SY; Uleryk, EM | 1 |
Akhavanpoor, M; Akyol, C; Beckendorf, J; Bruckner, T; Doesch, AO; Ehlermann, P; Erbel, C; Gleissner, CA; Helmschrott, M; Katus, HA; Ruhparwar, A; Schmack, B | 1 |
Hesselink, DA; van Gelder, T; van Schaik, RH | 1 |
Bunce, C; Calder, VL; Haskard, DO; Lightman, S; Longhurst, H; Lynn, W; Moots, R; Stanford, M; Taylor, SR; Tomkins-Netzer, O; Yang, D | 1 |
Bokström, H; Brännström, M; Dahm-Kähler, P; Diaz-Garcia, C; Ekberg, J; Enskog, A; Gäbel, M; Hagberg, H; Hanafy, A; Johannesson, L; Kvarnström, N; Milenkovic, M; Mölne, J; Nilsson, L; Olausson, M | 1 |
Avci, BK; Cakmak, HA; Cosansu, K; Erturk, E; Ikitimur, B; Karadag, B; Ongen, Z; Seyahi, N | 1 |
Chan, TM | 1 |
Mok, CC; Ng, WL; Siu, YP; To, CH; Tong, KH; Yim, CW; Ying, KY | 1 |
Akhavanpoor, M; Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Erbel, C; Frankenstein, L; Gleissner, CA; Helmschrott, M; Katus, HA; Klein, B; Rivinius, R; Ruhparwar, A; Schmack, B; Thomas, D | 1 |
Cotton, D | 1 |
Barraclough, KA; Burke, MT; Isbel, N; Jung, JW; Staatz, CE; Wells, JW | 1 |
de Bruin-Weller, MS; Deinum, J; Garritsen, FM; Roekevisch, E; Spuls, PI; van der Schaft, J | 1 |
Bao, H; Chen, YH; Hu, WX; Liu, ZH; Liu, ZZ; Wang, SF; Zhang, HT | 1 |
Montero, N; Pascual, J | 1 |
Guerra, C; Melo, J; Peña, C; Sepúlveda, C | 1 |
Huang, M; Li, JL; Shu, WY; Wang, XD | 1 |
Abe, T; Ichimaru, N; Imamura, R; Kaimori, JY; Kakuta, Y; Kato, T; Nonomura, N; Takahara, S; Yamanaka, K | 1 |
Karam, S; Wali, RK | 1 |
Aktürk, S; Çelebi, ZK; Erdoğmuş, Ş; Kanmaz, AG; Keven, K; Şengül, Ş; Yüce, T | 1 |
Mok, CC | 1 |
Adams, DH; Füssel, K; Hirschfield, GM; Hodson, J; Lohse, AW; Mann, J; Oo, YH; Schramm, C; Than, NN; Weiler-Normann, C; Wiegard, C | 1 |
Ashizuka, S; Inatsu, H; Kita, T; Kitamura, K | 1 |
Anglicheau, D; Babinet, F; Caillard, S; Colosio, C; Deslée, G; Dury, S; Essig, M; Etienne, I; Launois, C; Lebargy, F; Merieau, E; Perotin-Collard, JM; Rieu, P; Rivalan, J; Subra, JF; Thervet, E; Toubas, O | 1 |
Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
Arellano, AL; Montané, E; Muñoz Gómez, MM; Olivé, A | 1 |
Borrás-Blasco, J; Casterá, E; Cortes, X; Fernendez, S; Molés, JR; Moreno, M; Rodríguez, J | 1 |
Bakardzhiev, I; Chokoeva, AA; Krasnaliev, I; Lotti, T; Tana, C; Tchernev, G; Wollina, U | 1 |
Ji, L; Qin, W; Tang, X; Yang, L; Zhang, X | 1 |
Wang, L; Zhang, FC; Zhang, X | 1 |
Thervet, É | 1 |
Benson, MD; Fix, OK; Lee, BK; Stock, PG | 1 |
Awdishu, L; Joy, MS | 1 |
Oddis, CV | 1 |
Amiya, E; Endo, M; Hatano, M; Imamura, T; Iriyama, T; Kinoshita, O; Kinugawa, K; Komuro, I; Nagamatsu, T; Nawata, K; Nitta, D; Ono, M; Takahashi, Y | 1 |
Grossman, AB; Maxwell, EC | 1 |
Bobrowska, K; Cyganek, A; Czaplinska, N; Drozdowska-Szymczak, A; Jabiry-Zieniewicz, Z; Kociszewska-Najman, B; Pietrzak, B; Schreiber-Zamora, J; Wielgos, M | 1 |
Anderson, R; Bond, M; Coelho, H; Cooper, C; Crathorne, L; Dudley, J; Haasova, M; Huxley, N; Hyde, C; Jones-Hughes, T; Lowe, J; Marks, S; Mujica-Mota, R; Snowsill, T; Varley-Campbell, J | 1 |
Al Taii, H; Alkhouri, N; Hanouneh, I; Hanouneh, MA; Lopez, R; Zein, N | 1 |
Lee, YH; Song, GG | 1 |
Andrade, RJ; Bouma, G; Dalekos, GN; de Boer, YS; Floreani, A; Gleeson, D; Heneghan, MA; Hirschfield, GM; Invernizzi, P; Lenzi, M; Liberal, R; Lohse, AW; Macedo, G; Milkiewicz, P; Terziroli, B; van Hoek, B; Vierling, JM | 1 |
Bhari, N; Gupta, S | 1 |
Davidson, BR; Guerrero-Misas, M; Gurusamy, KS; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E | 1 |
Bellon, H; Heigl, T; Hoet, P; Lammertyn, E; Vanaudenaerde, BM; Vandermeulen, E; Vanhove, T; Verleden, GM; Verleden, SE; Verlinden, L; Verstuyf, M; Vos, R; Vriens, H | 1 |
Kamath, BM; Shah, PS; Valentino, PL; Zizzo, AN | 1 |
Chen, J; Chen, N; Fu, P; He, Y; Lin, H; Liu, F; Liu, J; Liu, Z; Ni, Z; Xing, C; Zeng, C; Zhang, H; Zhou, M | 1 |
Craig, JC; Flanc, RS; Henderson, L; Masson, P; Palmer, SC; Roberts, MA; Singh-Grewal, D; Strippoli, GF; Tong, A; Tunnicliffe, DJ; Webster, AC | 1 |
Codarin, FR; Festa Neto, C; Oliveira, WRP; Silva, LLC; Souza, AAV; Tirico, MCCP | 1 |
Doycheva, I; Gulamhusein, AF; Watt, KD | 1 |
Cristelli, M; de Paula, M; Felipe, C; Ferreira, AN; Medina Pestana, J; Tedesco-Silva, H; Viana, L | 1 |
Fujiwara, Y; Hosomi, S; Itani, S; Kakimoto, K; Kamata, N; Nagami, Y; Nishida, Y; Otani, K; Sugita, N; Taira, K; Tanaka, F; Tanigawa, T; Watanabe, T; Yamagami, H; Yukawa, T | 1 |
Chen, Y; Cong, Y; Dong, L; Omar, D | 1 |
Drenth, JPH; Mertens, C; Nevens, F; Pape, S; Tjwa, ETTL; Verslype, C | 1 |
Broen, JCA; van Laar, JM | 1 |
Andrews, PA; Hull, RP; Kingdon, EJ; MacPhee, IAM; Phanish, MK; Popoola, J | 1 |
Dong, L; Hu, T; Qin, W; Tan, J; Tang, Y; Tarun, P; Xu, Y; Ye, D; Zhong, Z | 1 |
Américo, MF; Caló, RS; Corá, LA; Dallagnol, DJR; Gama, LA; Miranda, JRA | 1 |
Ho, LY; Leung, MC; Mok, CC; Ng, WL; To, CH; Ying, SKY | 1 |
Bu, B; Du, C; Duan, RS; Liu, W; Shi, FD; Wang, L; Yang, H; Yang, L; Zeng, P; Zhang, C; Zhang, M | 1 |
Hata, K; Kiboshi, T; Konma, J; Kotani, T; Makino, H; Matsuda, S; Shiba, H; Shoda, T; Suzuka, T; Takeuchi, T; Wada, Y | 1 |
Cholevas, C; Dounousi, E; Eleftheriadis, T; Pissas, G; Raptis, G; Stefanidis, I; Theoharides, TC; Tziastoudi, M | 1 |
Ahn, SS; Lee, LE; Lee, SW; Park, YB; Pyo, JY; Song, JJ | 1 |
Croy, R; Erdman, J; Fitzsimmons, WE; Nimke, D; Schladt, D; Wang, X; Weaver, T; Wolfram, J | 2 |
Chen, N; Chen, X; Li, X; Ren, H; Shen, P; Xie, J; Xing, P; Zhang, Q; Zhang, W | 1 |
Edwards Mayhew, RG; Leslie, L; Li, T; McCann, P; Palestine, AG; Strong Caldwell, A | 1 |
Kim, JK | 1 |
Blokzijl, H; Kramer, S; van der Heide, F; van Hee, K; Visschedijk, MC | 1 |
Camacho, I; Dave, Y; Eckembrecher, DG; Eckembrecher, FJ; Nouri, K; Patel, S; Shah, H | 1 |
Ávila, D; Huertas, J; Mendoza, F; Ordóñez, A; Orozco, E; Sanmartin, D; Tamayo, C | 1 |
Jiang, N; Jin, S; Li, M; Tian, X; Wang, Q; Yu, C; Zeng, X; Zhao, J | 1 |
108 review(s) available for azathioprine and tacrolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Immunosuppressive drugs in renal transplantation. A review of the regimens.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Kidney Transplantation; Neoplasms; Prednisolone; Tacrolimus | 1992 |
The pharmacology of immunosuppression.
Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Cyclosporins; Humans; Immunosuppressive Agents; Tacrolimus | 1991 |
Combination drug therapies for immunosuppression in transplantation.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Prednisolone; Tacrolimus; Transplantation Immunology | 1991 |
New immunosuppressive drugs--pharmacologic approaches to alter immunoregulation.
Topics: Animals; Antimetabolites; Azathioprine; Biphenyl Compounds; Cell Differentiation; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytes; Lymphokines; Oligonucleotides, Antisense; Polyenes; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; Tacrolimus | 1994 |
Important interactions of drugs with immunosuppressive agents used in transplant recipients.
Topics: Azathioprine; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Prednisone; Tacrolimus; Transplantation; Transplantation, Homologous | 1995 |
The use of therapeutic drug monitoring to optimise immunosuppressive therapy.
Topics: Autoimmune Diseases; Azathioprine; CD3 Complex; Chromatography, High Pressure Liquid; Cyclosporine; Drug Delivery Systems; Drugs, Investigational; Enzyme-Linked Immunosorbent Assay; Humans; Immunosuppressive Agents; Monitoring, Immunologic; Radioimmunoassay; Structure-Activity Relationship; Tacrolimus | 1996 |
[Therapy of autoimmune hepatitis].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Budesonide; Cyclosporins; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Prednisolone; Pregnenediones; Prognosis; Tacrolimus; Time Factors | 1996 |
Update on therapy for refractory dermatomyositis and polymyositis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Polymyositis; Tacrolimus | 1996 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes.
Topics: Adrenal Cortex Hormones; Azathioprine; Breast Feeding; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prognosis; Tacrolimus; Transplantation, Homologous | 1998 |
Immunosuppression in uveitis therapy.
Topics: Administration, Oral; Administration, Topical; Animals; Arrestin; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Methotrexate; Rats; Steroids; Tacrolimus; Uveitis | 1999 |
[Immunosuppressive treatment of ulcerative colitis].
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Cytokines; Depression, Chemical; Humans; Immunosuppressive Agents; Mercaptopurine; Tacrolimus | 1999 |
Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Drug Interactions; Drug Monitoring; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Muromonab-CD3; Mycophenolic Acid; Receptors, Interleukin-2; Steroids; Tacrolimus; Transplantation Immunology | 1999 |
Immunosuppression in older renal transplant patients.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Antilymphocyte Serum; Azathioprine; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Quality of Life; Survival Analysis; Tacrolimus; Treatment Outcome | 2000 |
Other novel immunosuppressants.
Topics: Azathioprine; Chlorambucil; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Skin Diseases; Tacrolimus; Thioguanine | 2000 |
Evolving treatment strategies for inflammatory bowel disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Methotrexate; Mycophenolic Acid; Steroids; Tacrolimus | 2001 |
[Immunodeficiency induced by immunosuppressive agents].
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Methotrexate; Opportunistic Infections; Prednisolone; Prognosis; Tacrolimus | 2000 |
Pharmacological surrogates of allograft outcome.
Topics: Animals; Azathioprine; Cyclosporine; Drug Monitoring; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Sirolimus; Steroids; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine.
Topics: Azathioprine; Chromatography, High Pressure Liquid; Cyclosporine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Kidney Transplantation; Mercaptopurine; Tacrolimus; Time Factors | 2001 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Resistance; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Polymyositis; Steroids; Tacrolimus | 2001 |
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Azathioprine; Celiac Disease; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Osteoporosis; Prednisolone; Pruritus; Tacrolimus; Ursodeoxycholic Acid | 2001 |
Annual trends and triple therapy--1991-2000.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Kidney Transplantation; Living Donors; Middle Aged; Tacrolimus | 2001 |
Treatment strategies in autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Clinical Trials as Topic; Cyclosporine; Disease Progression; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
Topics: Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rheumatic Diseases; Severity of Illness Index; Sirolimus; Tacrolimus; Transplants; Treatment Outcome | 2003 |
[Auto-immune hepatitis: therapeutic management].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence; Remission Induction; Risk Factors; Steroids; Tacrolimus; Treatment Outcome | 2003 |
Anemia in children after transplantation: etiology and the effect of immunosuppressive therapy on erythropoiesis.
Topics: Anemia; Anemia, Iron-Deficiency; Azathioprine; Bone Marrow; Child; Erythropoiesis; Erythropoietin; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Tacrolimus | 2003 |
Renal transplantation: basic concepts and evolution of therapy.
Topics: Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Fingolimod Hydrochloride; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Receptors, Interleukin-2; Sirolimus; Sphingosine; Tacrolimus | 2003 |
[Treatment of autoimmune hepatitis].
Topics: Azathioprine; Folic Acid Antagonists; Hepatitis, Autoimmune; Humans; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Liver Transplantation; Methotrexate; Mycophenolic Acid; Tacrolimus; Tumor Necrosis Factor-alpha | 2003 |
[Immunomodulation in penetrating keratoplasty. Current status and perspectives].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Animals; Antiviral Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Keratoplasty, Penetrating; Methotrexate; Mice; Multicenter Studies as Topic; Mycophenolic Acid; Pilot Projects; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus | 2003 |
Pemphigus: current therapy.
Topics: Animals; Antirheumatic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Dog Diseases; Dogs; Glucocorticoids; Immunoglobulins, Intravenous; Mycophenolic Acid; Niacinamide; Organogold Compounds; Pemphigus; Sulfasalazine; Tacrolimus; Tetracycline | 2004 |
Low toxicity immunosuppressive protocols in renal transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Prospective Studies; Random Allocation; Retrospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
[Nocardiosis--is it frequently observed after the introduction of new immunosuppressive agents in renal transplantation?].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diabetes Complications; Disease Susceptibility; Female; Graft Rejection; Hepatitis C, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Nocardia asteroides; Nocardia Infections; Postoperative Complications; Reoperation; Risk Factors; Tacrolimus; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Immunosuppression and modulation in liver transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Glucocorticoids; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Living Donors; Mycophenolic Acid; Sirolimus; Tacrolimus | 2004 |
Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Postoperative Care; Safety; Sirolimus; Tacrolimus; Transplantation, Homologous | 2004 |
What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Topics: Azathioprine; Calcineurin Inhibitors; Child; Clinical Trials as Topic; Cyclosporine; Growth and Development; Hematologic Neoplasms; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Sirolimus; Tacrolimus | 2004 |
[Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Ribonucleosides; Tacrolimus | 2004 |
[Chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Efficacy of conventional immunosuppressive drugs in IBD.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide | 2004 |
Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Topics: Administration, Oral; Adrenal Cortex Hormones; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Everolimus; Graft Rejection; Growth Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation, Homologous | 2004 |
Pharmacokinetics of immunosuppressants: a perspective on ethnic differences.
Topics: Azathioprine; Black People; Cyclosporine; Cytochrome P-450 Enzyme System; Everolimus; Graft Survival; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; White People | 2004 |
[Immunossupresive drugs in renal transplantation].
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Risk Factors; Rituximab; Sirolimus; Sphingosine; Tacrolimus | 2004 |
[Organ transplantation: epidemiological and immunological aspects; principles of treatment and surveillance; complications and prognosis; ethical and legal aspects].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Liver Transplantation; Lung Transplantation; Lymphocyte Activation; Organ Transplantation; Pancreas Transplantation; Postoperative Complications; T-Lymphocytes; Tacrolimus; Time Factors; Tissue and Organ Harvesting; Tissue Donors; Transplantation Immunology; Waiting Lists | 2004 |
[Lung transplantation].
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporins; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Japan; Living Donors; Lung Transplantation; Methylprednisolone; Monitoring, Physiologic; Mycophenolic Acid; Survival Rate; Tacrolimus; Tissue and Organ Procurement | 2005 |
[Immunosuppressants for therapy of patients with ulcerative colitis].
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Guanine Nucleotides; Humans; Immunosuppressive Agents; Mercaptopurine; Methyltransferases; Mycophenolic Acid; Tacrolimus; Thionucleotides | 2005 |
[New therapies for inflammatory bowel disease].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytapheresis; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Tacrolimus | 2005 |
Treatment of focal segmental glomerulosclerosis.
Topics: Alkylating Agents; Antimetabolites; Azathioprine; Contraindications; Cyclophosphamide; Cyclosporine; Drug Resistance; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunophilins; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Podocytes; Randomized Controlled Trials as Topic; Tacrolimus | 2005 |
Review of major clinical trials with mycophenolate mofetil in renal transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Child; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Multicenter Studies as Topic; Mycophenolic Acid; Receptors, Interleukin-2; Sirolimus; Tacrolimus | 2005 |
Malignancy after transplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Neoplasms; Sirolimus; Skin Neoplasms; Tacrolimus; Transplantation Immunology; Transplantation, Homologous | 2005 |
[Immunosuppressive drug therapy during pregnancy after kidney transplantation].
Topics: Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Tacrolimus | 2005 |
Post-transplant de novo malignancies in renal transplant recipients: the past and present.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Europe; Female; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Neoplasms; Ohio; Registries; Sirolimus; Tacrolimus; United States | 2006 |
Azathioprine, UV light, and skin cancer in organ transplant patients--do we have an answer?
Topics: Azathioprine; Carcinoma, Squamous Cell; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Risk Factors; Skin Neoplasms; Tacrolimus; Ultraviolet Rays | 2007 |
Immunosuppression for lung transplantation: evidence to date.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus | 2007 |
Immunosuppressive agents for myasthenia gravis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Myasthenia Gravis; Mycophenolic Acid; Prednisolone; Randomized Controlled Trials as Topic; Tacrolimus | 2007 |
[Malignant tumors following renal transplantation].
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Muromonab-CD3; Neoplasms; Prognosis; Sarcoma, Kaposi; Skin Neoplasms; Tacrolimus | 2007 |
[Ulcerative colitis].
Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Drugs, Chinese Herbal; Humans; Immunosuppressive Agents; Mercaptopurine; Prednisolone; Sulfasalazine; Tacrolimus; Time Factors | 2007 |
Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Sirolimus; Tacrolimus | 2008 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
Management of chronic allograft nephropathy: a systematic review.
Topics: Azathioprine; Biopsy; Calcineurin Inhibitors; Chronic Disease; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Mycophenolic Acid; Sirolimus; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Surgical biology for the clinician: vascular effects of immunosuppression.
Topics: Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclosporine; Delayed Graft Function; Endothelium, Vascular; Everolimus; Graft Rejection; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Tolerance; Immunosuppressive Agents; Sirolimus; Tacrolimus; Transplantation Immunology | 2010 |
[Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome].
Topics: Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Glomerulonephritis; Humans; Immunosuppressive Agents; Mercaptopurine; Methylprednisolone; Nephrotic Syndrome; Prednisolone; Remission Induction; Rituximab; Tacrolimus | 2010 |
[Immunosuppressive therapies for refractory nephrotic syndrome].
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Monitoring; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Polymorphism, Genetic; Ribonucleosides; Rituximab; Tacrolimus | 2010 |
Management of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Drug Hypersensitivity; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Purine-Pyrimidine Metabolism, Inborn Errors; Tacrolimus | 2011 |
[Secondary membranous nephropathy: The topics of membranous lupus nephritis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Calcineurin Inhibitors; Drug Therapy, Combination; Fluorouracil; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lupus Nephritis; Mitomycin; Prognosis; Ribonucleosides; Semustine; Tacrolimus | 2011 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
Current treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Cyclosporine; Endoscopy; Gastroenterology; Humans; Infliximab; Mercaptopurine; Mesalamine; Remission Induction; Steroids; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell Movement; Cyclophosphamide; Cyclosporine; Dermatomyositis; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Paraneoplastic Syndromes; Physical Therapy Modalities; Polymyositis; T-Lymphocytes; Tacrolimus | 2011 |
Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Dapsone; Dermatologic Agents; Epidermal Growth Factor; Evidence-Based Medicine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Medicine, Chinese Traditional; Mycophenolic Acid; Pemphigus; Pentoxifylline; Plasmapheresis; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2011 |
Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Multiple Organ Failure; Mycophenolic Acid; Paraneoplastic Syndromes; Pemphigus; Plasmapheresis; Rituximab; Tacrolimus | 2011 |
Immunosuppression and HCV recurrence after liver transplantation.
Topics: Azathioprine; Cyclosporine; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Tacrolimus | 2012 |
Effects of immunosuppressive therapy on wound healing.
Topics: Animals; Azathioprine; Cyclosporine; Everolimus; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rats; Sirolimus; Swine; Tacrolimus; Wound Healing; Wounds and Injuries | 2013 |
Immunotherapies in neurologic disorders.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Fingolimod Hydrochloride; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Mitoxantrone; Mycophenolic Acid; Natalizumab; Nervous System Diseases; Peptides; Plasma Exchange; Propylene Glycols; Rituximab; Sphingosine; Tacrolimus | 2012 |
Therapeutic advances in myositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunomodulation; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Polymyositis; Randomized Controlled Trials as Topic; Tacrolimus | 2012 |
Immunosuppression in HCV-positive liver-transplant recipients.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Azathioprine; Basiliximab; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Daclizumab; Everolimus; Hepatitis C; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2012 |
Update on pregnancy and breastfeeding in the era of biologics.
Topics: Adalimumab; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Breast Feeding; Certolizumab Pegol; Colitis, Ulcerative; Contraindications; Crohn Disease; Cyclosporine; Female; Fertility; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Natalizumab; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Tacrolimus | 2013 |
Pregnancy in renal transplant recipients.
Topics: Anemia; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Female; Herpes Simplex; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Preconception Care; Prednisone; Pregnancy; Pregnancy Complications; Tacrolimus; Toxoplasmosis; Urinary Tract Infections | 2013 |
Calcineurin inhibitors in HLA-identical living related donor kidney transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Calcineurin Inhibitors; Child; Creatinine; Cyclosporine; Female; Graft Rejection; Graft Survival; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Tacrolimus; Young Adult | 2014 |
Clinical management of inflammatory bowel disease in the organ recipient.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Graft Rejection; Heart Transplantation; Humans; Inflammatory Bowel Diseases; Kidney Transplantation; Liver Transplantation; Mesalamine; Risk Factors; Tacrolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Prednisone; Remission Induction; Tacrolimus; Treatment Outcome | 2014 |
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.
Topics: Azathioprine; Cyclosporine; Drug Monitoring; Everolimus; Evidence-Based Medicine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Organ Transplantation; Pharmacogenetics; Polymorphism, Genetic; Predictive Value of Tests; Sirolimus; Tacrolimus; Transplantation Immunology | 2014 |
Treatment of severe lupus nephritis: the new horizon.
Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus | 2015 |
Genetics and nonmelanoma skin cancer in kidney transplant recipients.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Pharmacogenetics; Prednisolone; Prednisone; Skin Neoplasms; Tacrolimus | 2015 |
Immunosuppression and Post-transplant Hyperglycemia.
Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Everolimus; Graft Rejection; Humans; Hyperglycemia; Immunosuppressive Agents; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation | 2015 |
Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese population.
Topics: Anticoagulants; Asian People; Azathioprine; China; Cyclophosphamide; Cyclosporine; Gene Frequency; Genotype; Humans; Immunosuppressive Agents; Pharmacogenetics; Phenotype; Precision Medicine; Tacrolimus; Warfarin | 2015 |
Current State of Immunosuppression: Past, Present, and Future.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus | 2015 |
Mycophenolate mofetil for lupus nephritis: an update.
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Lupus Nephritis; Mycophenolic Acid; Tacrolimus | 2015 |
The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Randomized Controlled Trials as Topic; Tacrolimus | 2016 |
Therapeutic advances for primary biliary cholangitis: the old and the new.
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cyclosporine; Enzyme Inhibitors; Fibric Acids; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Liver Cirrhosis, Biliary; Mesenchymal Stem Cell Transplantation; Methotrexate; Mycophenolic Acid; Pyridones; Rituximab; Tacrolimus; Ursodeoxycholic Acid; Ustekinumab | 2016 |
Role of Pharmacogenomics in Kidney Disease and Injury.
Topics: Acute Kidney Injury; Azathioprine; Calcineurin Inhibitors; Cisplatin; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzymes; Glomerulonephritis; Humans; Hydroxychloroquine; Membrane Transport Proteins; Mycophenolic Acid; Pharmacogenetics; Polymorphism, Genetic; Rituximab; Tacrolimus; Tenofovir | 2016 |
Update on the pharmacological treatment of adult myositis.
Topics: Adrenocorticotropic Hormone; Adult; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Myositis; Tacrolimus | 2016 |
Advances in Pediatric Inflammatory Bowel Disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus | 2016 |
Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
Topics: Abatacept; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Therapy, Combination; Everolimus; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Models, Economic; Mycophenolic Acid; Recombinant Fusion Proteins; Sirolimus; Tacrolimus; Technology Assessment, Biomedical | 2016 |
Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
Topics: Azathioprine; Bayes Theorem; Cyclophosphamide; Humans; Long-Term Care; Lupus Nephritis; Mycophenolic Acid; Randomized Controlled Trials as Topic; Tacrolimus; Treatment Outcome | 2017 |
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclosporine; Drug Therapy, Combination; Everolimus; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Retreatment; Sirolimus; Tacrolimus; Transplantation Immunology | 2017 |
Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
Topics: Azathioprine; Child; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Induction Chemotherapy; Models, Statistical; Mycophenolic Acid; Pediatrics; Prednisone; Tacrolimus; Treatment Outcome | 2017 |
Immunosuppressive treatment for proliferative lupus nephritis.
Topics: Adult; Azathioprine; Calcineurin; Child; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus | 2018 |
Autoimmune hepatitis: Current and future therapeutic options.
Topics: Animals; Azathioprine; Disease Management; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Mycophenolic Acid; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Tacrolimus | 2019 |
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Recurrence; Remission Induction; Rituximab; Tacrolimus | 2020 |
Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology.
Topics: Antirheumatic Agents; Azathioprine; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Mycophenolic Acid; Rheumatic Diseases; Rheumatology; Tacrolimus | 2020 |
The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis.
Topics: Adult; Azathioprine; Clinical Trials as Topic; Drug Combinations; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Treatment Outcome | 2020 |
A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease.
Topics: Azathioprine; Cyclosporine; Humans; Pharmacogenomic Testing; Pharmacogenomic Variants; Polymorphism, Genetic; Prednisolone; Renal Insufficiency, Chronic; Tacrolimus; Treatment Outcome | 2021 |
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Macular Edema; Methotrexate; Mycophenolic Acid; Panuveitis; Steroids; Tacrolimus | 2022 |
[Treatment of Autoimmune Hepatitis].
Topics: Adult; Azathioprine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Tacrolimus | 2023 |
Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion.
Topics: Autoimmune Pancreatitis; Azathioprine; Exocrine Pancreatic Insufficiency; Expert Testimony; Humans; Immune Checkpoint Inhibitors; Pancreatitis; Steroids; Tacrolimus | 2023 |
A review of heart transplant immunosuppressants and nonmelanoma skin cancer.
Topics: Azathioprine; Everolimus; Heart Transplantation; Humans; Immunosuppressive Agents; Mycophenolic Acid; Sirolimus; Skin Neoplasms; Tacrolimus | 2023 |
Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Colombia; Cost-Benefit Analysis; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Tacrolimus | 2023 |
Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis.
Topics: Adult; Azathioprine; Bone Marrow Diseases; Cyclophosphamide; Glucocorticoids; Herpes Zoster; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Neoplasms; Network Meta-Analysis; Recurrence; Tacrolimus; Treatment Outcome | 2023 |
125 trial(s) available for azathioprine and tacrolimus
Article | Year |
---|---|
Quality-of-life advantages of FK 506 vs conventional immunosuppressive drug therapy in cardiac transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Female; Health Status; Heart Transplantation; Humans; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Prednisone; Quality of Life; Tacrolimus | 1991 |
Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation.
Topics: Acute Kidney Injury; Adult; Aged; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney; Liver Transplantation; Male; Middle Aged; Prednisone; Tacrolimus | 1994 |
FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart-Lung Transplantation; Humans; Methylprednisolone; Muromonab-CD3; Respiratory Function Tests; Tacrolimus; Time Factors | 1994 |
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.
Topics: Actuarial Analysis; Adult; Azathioprine; Cadaver; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Postoperative Complications; Prednisone; Prospective Studies; Survival Rate; Tacrolimus; Time Factors; Tissue Donors | 1994 |
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Creatinine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Tacrolimus | 1995 |
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group.
Topics: Adrenal Cortex Hormones; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Electrolytes; Glomerular Filtration Rate; Humans; Liver Transplantation; Reoperation; Tacrolimus; United States | 1995 |
FK 506 improves recovery of bile secretion following orthotopic liver transplantation in man.
Topics: Azathioprine; Bile; Bilirubin; Cyclosporine; Follow-Up Studies; Humans; Liver Transplantation; Prednisolone; Sweden; Tacrolimus; Time Factors | 1995 |
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine.
Topics: Adolescent; Adult; Antilymphocyte Serum; Apolipoprotein A-I; Apolipoproteins B; Azathioprine; Bilirubin; Cholesterol; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Europe; Humans; Lidocaine; Liver Function Tests; Liver Transplantation; Methylprednisolone; Middle Aged; Prednisolone; Tacrolimus; Time Factors | 1995 |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Li
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Incidence; Liver Diseases; Liver Neoplasms; Liver Transplantation; Male; Steroids; Survival Rate; Tacrolimus | 1995 |
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Azathioprine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Middle Aged; Postoperative Complications; Prednisone; Prospective Studies; Reoperation; Survival Rate; Tacrolimus; Time Factors | 1995 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Two-year experience with FK 506 in pediatric patients.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Intestine, Small; Liver Transplantation; Lung Transplantation; Lymphoproliferative Disorders; Prednisone; Survival Analysis; Tacrolimus | 1993 |
Outcome analysis of FK 506 therapy for acute and chronic rejection.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Male; Tacrolimus; Time Factors; Treatment Outcome | 1993 |
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
Topics: Actuarial Analysis; Adrenal Cortex Hormones; Azathioprine; Biopsy; Cyclosporine; Graft Rejection; Humans; Liver Transplantation; Muromonab-CD3; Tacrolimus; Transplantation, Homologous | 1993 |
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients.
Topics: Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Immunosuppression Therapy; Kidney; Liver Transplantation; Male; Middle Aged; Prednisone; Tacrolimus | 1993 |
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
Topics: Actuarial Analysis; Adult; Azathioprine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Function Tests; Kidney Transplantation; Prednisone; Survival Analysis; Tacrolimus | 1993 |
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection.
Topics: Adult; Azathioprine; Bilirubin; Biopsy; Cyclosporine; Drug Resistance; Female; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Middle Aged; Prednisone; Retrospective Studies; Tacrolimus; Time Factors | 1993 |
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
Topics: Adult; Azathioprine; Black People; Cholesterol; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Prednisone; Retrospective Studies; Tacrolimus | 1993 |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Topics: Antilymphocyte Serum; Azathioprine; Drug Resistance; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Muromonab-CD3; Prednisolone; Prospective Studies; Retrospective Studies; Steroids; Tacrolimus | 1993 |
Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients.
Topics: Analysis of Variance; Azathioprine; Blood Glucose; Body Mass Index; C-Peptide; Cyclosporine; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Glycerol; Humans; Insulin; Ketone Bodies; Lactates; Liver Transplantation; Male; Middle Aged; Prospective Studies; Pyruvates; Pyruvic Acid; Reference Values; Tacrolimus | 1993 |
Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
Topics: Adolescent; Adult; Aged; Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immune Tolerance; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Prednisolone; Prospective Studies; Rabbits; Tacrolimus | 1995 |
Current advantage of FK 506 in cadaveric kidney transplantation.
Topics: Antibodies, Monoclonal; Azathioprine; Cadaver; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Methylprednisolone; Patient Readmission; Survival Rate; Tacrolimus; Tissue Donors | 1996 |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Communicable Diseases; Coronary Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Incidence; Muromonab-CD3; Prednisone; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous | 1996 |
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Topics: Adolescent; Adult; Amylases; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Pancreas Transplantation; Recurrence; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 1996 |
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
Topics: Antilymphocyte Serum; Azathioprine; Biopsy; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Prednisone; Tacrolimus; Time Factors; Transplantation, Homologous | 1996 |
UCLA liver transplantation: analysis of immunological factors affecting outcome.
Topics: Adult; Antibody Specificity; Asian People; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclosporine; Flow Cytometry; Graft Rejection; Hepatitis B Surface Antigens; Hispanic or Latino; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Transplantation; Postoperative Complications; Prospective Studies; Steroids; Tacrolimus; White People | 1996 |
FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
Topics: Adult; Anti-Infective Agents; Azathioprine; Contraindications; Creatinine; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Steroids; Tacrolimus; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
Topics: Adolescent; Adult; Azathioprine; Child; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Postoperative Complications; Prednisone; Prospective Studies; Tacrolimus | 1997 |
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Gastrointestinal Diseases; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Kidney Transplantation; Lymphoma; Male; Muromonab-CD3; Mycophenolic Acid; Nervous System Diseases; Pancreas Transplantation; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous | 1997 |
Outcomes in diabetic patients after simultaneous pancreas-kidney versus kidney alone transplantation.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Retrospective Studies; Tacrolimus; Treatment Outcome | 1997 |
Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prednisone; Tacrolimus; Uremia | 1997 |
Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.
Topics: Adult; Azathioprine; Creatinine; Cyclosporine; Female; Humans; Hypertension, Renovascular; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Tacrolimus; Vascular Resistance; Vasoconstriction | 1998 |
Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Humans; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Paraproteinemias; Tacrolimus | 1998 |
Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Pancreas Transplantation; Prospective Studies; Tacrolimus; Transplantation, Homologous | 1998 |
Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.
Topics: Antilymphocyte Serum; Azathioprine; Cholesterol; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins; Muromonab-CD3; Risk Factors; Survival Rate; Tacrolimus; Triglycerides | 1998 |
Tacrolimus therapy for ABO-incompatible kidney transplantation.
Topics: ABO Blood-Group System; Adult; Antilymphocyte Serum; Azathioprine; Blood Group Incompatibility; Drug Therapy, Combination; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Survival Rate; Tacrolimus | 1998 |
Preoperative induction with tacrolimus does not have a detrimental effect on primary graft function in adult cadaveric renal transplantation.
Topics: Adult; Azathioprine; Cadaver; Dopamine; Drug Administration Schedule; Furosemide; Humans; Immunosuppressive Agents; Kidney Transplantation; Mannitol; Methylprednisolone; Prospective Studies; Tacrolimus; Tissue Donors | 1998 |
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
Topics: Acute Disease; Adolescent; Adult; Aged; Azathioprine; Biopsy, Needle; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Survival Rate; Tacrolimus | 1998 |
Tacrolimus for rescue of refractory renal allograft rejection.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Prednisone; Tacrolimus | 1998 |
Early posttransplantation renal hemodynamics in FK 506-treated kidney recipients with or without prior induction therapy.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Blood Pressure; Creatinine; Drug Therapy, Combination; Glomerular Filtration Rate; Hemodynamics; Humans; Immunosuppressive Agents; Kidney Transplantation; Nephrectomy; Prednisone; Regional Blood Flow; Renal Circulation; Tacrolimus | 1998 |
FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Child; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Prospective Studies; Tacrolimus; United States | 1998 |
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
Topics: Adrenal Cortex Hormones; Azathioprine; Cholesterol; Cyclosporine; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins; Tacrolimus; Time Factors | 1998 |
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
Topics: Adult; Azathioprine; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Prednisone; Prospective Studies; Survival Rate; Tacrolimus; Time Factors | 1998 |
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Cause of Death; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Survival Rate; Tacrolimus | 1998 |
Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
Topics: Analysis of Variance; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Liver Transplantation; Postoperative Complications; Prednisone; Prospective Studies; Regression Analysis; Survival Rate; Tacrolimus; Time Factors | 1998 |
Risk and benefit of antibody induction therapy in combination with tacrolimus immunosuppression after liver transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Muromonab-CD3; Prednisolone; Prospective Studies; Risk Assessment; Survival Rate; Tacrolimus | 1998 |
FK506 rescue therapy in lung transplantation.
Topics: Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart-Lung Transplantation; Humans; Lung Transplantation; Patient Selection; Prednisolone; Tacrolimus | 1998 |
Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
Topics: Adult; Analysis of Variance; Azathioprine; Communicable Diseases; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney Function Tests; Liver Transplantation; Methylprednisolone Hemisuccinate; Postoperative Complications; Regression Analysis; Retrospective Studies; Tacrolimus | 1998 |
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Methylprednisolone; Middle Aged; Neoplasms; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors | 1998 |
Vascular microthrombosis in renal transplant recipients treated with tacrolimus.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Microcirculation; Middle Aged; Renal Circulation; Tacrolimus; Thrombosis | 1998 |
Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506.
Topics: Adult; Aged; Azathioprine; Cardiomyopathy, Dilated; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Tacrolimus; Taiwan | 1998 |
Primary prophylaxis with tacrolimus in kidney transplants in China.
Topics: Adult; Antilymphocyte Serum; Azathioprine; China; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Hepatitis B Surface Antigens; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Time Factors | 1998 |
Evaluation of immunosuppressive induction regimens in renal transplantation. Collaborative Transplant Study.
Topics: Adrenal Cortex Hormones; Azathioprine; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Reoperation; Tacrolimus; Time Factors | 1998 |
A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
Topics: Adult; Azathioprine; Black People; Cadaver; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Tacrolimus; Transplantation Immunology; Treatment Outcome | 1999 |
Tacrolimus and glucose metabolism.
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Glucose; C-Peptide; Cyclosporine; Female; Fructosamine; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Prednisone; Prospective Studies; Regression Analysis; Tacrolimus | 1999 |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation.
Topics: Adolescent; Adult; Azathioprine; Blood Pressure; Child; Child, Preschool; Diuresis; Drug Therapy, Combination; Female; Heart Rate; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Transplantation; Male; Middle Aged; Prednisone; Tacrolimus | 1999 |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
Topics: Azathioprine; Blood Pressure; Cholesterol; Creatinine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Methylprednisolone; Mycophenolic Acid; Risk Factors; Survival Rate; Tacrolimus; Triglycerides | 1999 |
Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Creatinine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Transplantation; Methylprednisolone; Middle Aged; Prospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome | 1999 |
Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Rectal Fistula; Recurrence; Tacrolimus; Treatment Outcome | 1999 |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Care; Prospective Studies; Tacrolimus | 2000 |
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Topics: Acute Disease; Adult; Azathioprine; Cadaver; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Treatment Failure; Treatment Outcome | 2000 |
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver; Liver Transplantation; Male; Middle Aged; Prednisolone; Prospective Studies; Survival Analysis; Tacrolimus | 2000 |
Oral tacrolimus treatment of severe colitis in children.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infant; Male; Mercaptopurine; Prospective Studies; Remission Induction; Severity of Illness Index; Tacrolimus | 2000 |
Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Tacrolimus | 2000 |
Clinical study of FK 506 in renal transplant recipients.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Tacrolimus | 2000 |
Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
Topics: Azathioprine; China; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Mycophenolic Acid; Prednisone; Tacrolimus; Time Factors | 2000 |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis.
Topics: Adult; Aged; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Prednisone; Tacrolimus; Time Factors; Tissue Donors | 2000 |
Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation.
Topics: Adolescent; Adult; Area Under Curve; Azathioprine; Child; Creatinine; Drug Therapy, Combination; Female; Graft Rejection; Half-Life; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Ribonucleosides; Tacrolimus | 2000 |
Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Topics: Adult; Azathioprine; Cadaver; Cause of Death; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisolone; Survival Rate; Tacrolimus; Time Factors; Tissue Donors | 2000 |
Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Arrest; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Survival Rate; Tacrolimus; Time Factors; Tissue Donors | 2000 |
Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients.
Topics: Asian People; Azathioprine; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Hong Kong; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Prednisolone; Tacrolimus | 2000 |
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients.
Topics: Adolescent; Adult; Aged; Azathioprine; Cohort Studies; Creatinine; Cyclosporine; Drug Therapy, Combination; Europe; Female; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Prednisolone; Renal Insufficiency; Tacrolimus | 1994 |
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors | 1994 |
Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
Topics: Adult; Analysis of Variance; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Lung Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Tacrolimus; Time Factors | 2001 |
Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Drug Therapy, Combination; Ethnicity; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Patient Selection; Reoperation; Safety; Survival Rate; Tacrolimus; Treatment Outcome | 2001 |
Management of massive proteinuria following renal transplantation with mycophenolate mofetil and blood pressure normalization.
Topics: Azathioprine; Biopsy; Blood Pressure; Cholesterol; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Proteinuria; Tacrolimus; Triglycerides | 2001 |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial.
Topics: Antilymphocyte Serum; Azathioprine; Bacterial Infections; Cytomegalovirus Infections; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Muromonab-CD3; Mycoses; Postoperative Complications; Prednisolone; Prospective Studies; Sepsis; Survival Rate; Tacrolimus; Time Factors | 2001 |
Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation.
Topics: Azathioprine; Cohort Studies; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Prospective Studies; Survival Rate; Tacrolimus; Time Factors | 2001 |
An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Calcineurin; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Patient Selection; Postoperative Complications; Reoperation; Steroids; Survival Rate; Tacrolimus; Time Factors | 2001 |
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
Topics: Administration, Oral; Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Black People; Cadaver; Child; Cross-Over Studies; Cyclosporine; Diabetes Mellitus; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Insulin; Kidney Function Tests; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Mycophenolic Acid; Postoperative Complications; Survival Rate; Tacrolimus; Time Factors; Tissue Donors; United States; White People | 2001 |
Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Emulsions; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus; Transplantation Immunology; Treatment Outcome | 2002 |
Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
Topics: Adrenal Cortex Hormones; Azathioprine; Cadaver; Cholesterol; Creatinine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Postoperative Complications; Spain; Survival Rate; Tacrolimus; Time Factors; Tissue Donors | 2002 |
Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Safety; Tacrolimus; Time Factors | 2002 |
Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
Topics: Azathioprine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Time Factors | 2002 |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Resistance; Emulsions; Europe; Follow-Up Studies; Graft Rejection; Humans; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Safety; Tacrolimus; Time Factors | 2002 |
Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukopenia; Middle Aged; Postoperative Complications; Spain; Tacrolimus; Time Factors; Treatment Outcome | 2002 |
One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Brazil; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Infections; Kidney Transplantation; Male; Postoperative Complications; Protozoan Infections; Tacrolimus; Time Factors | 2002 |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients.
Topics: Administration, Oral; Area Under Curve; Azathioprine; Humans; Immunosuppressive Agents; Kidney Transplantation; Metabolic Clearance Rate; Mycophenolic Acid; Tacrolimus; Time Factors | 2002 |
Effects of three immunosuppressive regimens on CD4 helper function, B cell monocyte and cytokine responses in renal transplant recipients: 4-month follow-up of a prospective randomized study.
Topics: Azathioprine; B-Lymphocytes; Cells, Cultured; Coculture Techniques; Cyclosporine; Cytokines; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Interleukin-10; Kidney Transplantation; Mycophenolic Acid; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Tacrolimus; Time Factors | 2002 |
Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
Topics: Adult; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Reoperation; Steroids; Tacrolimus; Tissue Donors | 2002 |
Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Survival Analysis; Tacrolimus; Time Factors | 2002 |
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
Topics: Acute Disease; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Florida; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hyperglycemia; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Probability; Racial Groups; Survival Analysis; Tacrolimus; Time Factors; Tissue Donors | 2003 |
Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up.
Topics: Acute Disease; Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Creatinine; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Italy; Kidney Transplantation; Recurrence; Spain; Survival Analysis; Tacrolimus; Time Factors | 2003 |
36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil.
Topics: Adrenal Cortex Hormones; Azathioprine; Creatinine; Diabetes Mellitus; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Survival Analysis; Tacrolimus; Time Factors | 2003 |
Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Female; Fibrosis; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Male; Middle Aged; Prednisone; Steroids; Tacrolimus; Treatment Outcome | 2004 |
Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
Topics: Agammaglobulinemia; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Heart Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus | 2005 |
Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Injections, Intravenous; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Prednisolone; Tacrolimus | 2005 |
Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens.
Topics: Adolescent; Adult; Aged; Azathioprine; Creatinine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Steroids; Tacrolimus | 2005 |
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Tacrolimus | 2005 |
An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: a comparison of dual vs. triple drug therapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2005 |
Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Cyclosporine; Emulsions; Europe; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Function Tests; Kidney Transplantation; Male; Prospective Studies; Tacrolimus | 2005 |
Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prednisolone; Secondary Prevention; Survival Analysis; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2006 |
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine.
Topics: Adult; Aged; Azathioprine; B-Lymphocytes; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Killer Cells, Natural; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; T-Lymphocytes; Tacrolimus | 2006 |
Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels.
Topics: Azathioprine; Drug Therapy, Combination; Histocompatibility Testing; Humans; Immunoglobulin A; Immunoglobulin M; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Survival Analysis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2006 |
A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
Topics: Adult; Azathioprine; Bronchiolitis Obliterans; Bronchitis; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Postoperative Care; Tacrolimus | 2007 |
Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cardiovascular Diseases; Creatinine; Daclizumab; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Neoplasms; Opportunistic Infections; Prospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2008 |
Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
Topics: Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Prospective Studies; Tacrolimus; Transplantation, Homologous | 2008 |
Multicentre prospective randomised trial of tacrolimus, azathioprine and prednisolone with or without basiliximab: two-year follow-up data.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Basiliximab; Child; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisolone; Prospective Studies; Recombinant Fusion Proteins; Tacrolimus | 2009 |
Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
Topics: Adolescent; Adult; Aged; Azathioprine; Biopsy; Child; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Hepatitis C; Humans; Hypertension, Portal; Immunosuppressive Agents; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prednisolone; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Severity of Illness Index; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2009 |
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
Topics: Adult; Antiviral Agents; Azathioprine; Chemoprevention; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Renal Insufficiency; Risk Factors; Tacrolimus; Treatment Outcome | 2010 |
Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
Topics: Azathioprine; Bronchiolitis Obliterans; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lung Transplantation; Male; Middle Aged; Sirolimus; Tacrolimus; Time Factors | 2011 |
Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
Topics: Azathioprine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Lung Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus; Venous Thromboembolism | 2011 |
Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
Topics: Adolescent; Adult; Aged; Azathioprine; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Remission Induction; Secondary Prevention; Tacrolimus; Treatment Outcome; Young Adult | 2011 |
Impact of maintenance immunosuppressive regimens--balance between graft protective suppression of immune functions and a near physiological immune response.
Topics: Adult; Azathioprine; CD4-Positive T-Lymphocytes; Cyclosporine; Cytokines; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-10; Interleukin-2; Interleukin-4; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Tacrolimus; Treatment Outcome | 2011 |
Alemtuzumab preconditioning allows steroid-calcineurin inhibitor-free regimen in live-donor kidney transplant.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Azathioprine; Calcineurin Inhibitors; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Egypt; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Sirolimus; Steroids; Tacrolimus; Time Factors; Transplantation Conditioning; Treatment Outcome; Young Adult | 2011 |
A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Risk Assessment; Risk Factors; Steroids; Tacrolimus | 2012 |
Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Prospective Studies; Tacrolimus; Treatment Outcome | 2012 |
[Recent clinical trials on treatment of myasthenia gravis].
Topics: Azathioprine; Humans; Myasthenia Gravis; Mycophenolic Acid; Tacrolimus | 2012 |
A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up.
Topics: Adult; Azathioprine; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Steroids; Tacrolimus | 2013 |
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hypertension, Portal; Immunosuppressive Agents; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Prednisolone; Recurrence; Tacrolimus; Time Factors | 2014 |
Humoral immunity after kidney transplantation: impact of two randomized immunosuppressive protocols.
Topics: Azathioprine; B-Lymphocytes; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunity, Humoral; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Tacrolimus; Treatment Outcome | 2013 |
Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
Topics: Adult; Aged; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Pemphigus; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Young Adult | 2015 |
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Single-Blind Method; Surveys and Questionnaires; T-Lymphocytes, Regulatory; Tacrolimus; Th17 Cells; Treatment Outcome | 2015 |
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Creatinine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Induction Chemotherapy; Kidney Failure, Chronic; Lupus Nephritis; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Proteinuria; Recurrence; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2016 |
Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
Topics: Adult; Azathioprine; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Symptom Flare Up; Tacrolimus; Time; Treatment Outcome | 2020 |
286 other study(ies) available for azathioprine and tacrolimus
Article | Year |
---|---|
Immunomodulatory constituents from an Ascomycete, Eupenicillium crustaceum, and revised absolute structure of macrophorin D.
Topics: Adjuvants, Immunologic; Animals; Ascomycota; Azathioprine; B-Lymphocytes; Chromatography, High Pressure Liquid; Circular Dichroism; Concanavalin A; Cyclosporine; Drug Screening Assays, Antitumor; Immunosuppressive Agents; Inhibitory Concentration 50; Japan; Lipopolysaccharides; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Sesquiterpenes; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Spleen; Stereoisomerism; Structure-Activity Relationship; T-Lymphocytes; Tacrolimus; Tumor Cells, Cultured | 2001 |
Immunomodulatory constituents from an Ascomycete, Chaetomium seminudum.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Chaetomium; Disulfides; Heterocyclic Compounds, 4 or More Rings; Indole Alkaloids; Japan; Lymphocytes; Mice; Molecular Structure; Spleen | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506.
Topics: Animals; Azathioprine; Cyclosporine; DNA; Female; Liver Regeneration; Rats; Rats, Inbred Strains; Tacrolimus | 1992 |
Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions.
Topics: Animals; Azathioprine; Cyclosporine; Dexamethasone; DNA Replication; Dose-Response Relationship, Immunologic; Drug Interactions; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Mercaptopurine; Polyenes; Rats; Rats, Inbred BUF; Rats, Inbred WF; Sirolimus; Tacrolimus | 1992 |
FK 506 in canine renal transplantation.
Topics: Animals; Azathioprine; Cyclosporine; Dogs; Immunosuppression Therapy; Kidney Transplantation; Prednisolone; Tacrolimus; Transplantation, Homologous | 1992 |
Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome.
Topics: Anti-Bacterial Agents; Azathioprine; Bile Ducts; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Risk Factors; Tacrolimus | 1991 |
A protective effect of FK506 in ischemically injured rat livers.
Topics: Animals; Anti-Bacterial Agents; Azathioprine; Cyclosporins; Female; Immunosuppressive Agents; Ischemia; Lipid Peroxidation; Liver; Malondialdehyde; Rats; Rats, Inbred Strains; Tacrolimus; Time Factors | 1991 |
Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
Topics: Antigens, Differentiation, T-Lymphocyte; Azathioprine; CD3 Complex; Cells, Cultured; Cyclosporine; DNA Replication; Drug Interactions; Guanidines; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Phytohemagglutinins; Receptors, Antigen, T-Cell; Ribonucleosides; Tacrolimus | 1991 |
FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
Topics: Adult; Aged; Azathioprine; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Tacrolimus | 1991 |
Liver retransplantation in adults: overall results and determinant factors affecting the outcome.
Topics: Adult; Azathioprine; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Liver Transplantation; Middle Aged; Prednisone; Regression Analysis; Retrospective Studies; Tacrolimus; Treatment Outcome | 1991 |
Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation.
Topics: Azathioprine; Female; Graft Rejection; Humans; Kidney; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Prednisone; Tacrolimus | 1991 |
Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.
Topics: Adult; Azathioprine; Biopsy; Creatinine; Female; Ganciclovir; Hemolytic-Uremic Syndrome; Humans; Kidney Transplantation; Prednisone; Tacrolimus | 1991 |
Orthotopic liver transplantation at Addenbrooke's Hospital Cambridge 1968 to 1991.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cross-Cultural Comparison; Cyclosporine; England; Female; Follow-Up Studies; Graft Survival; Hepatic Encephalopathy; Humans; Immunosuppression Therapy; Infant; Infant, Newborn; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reoperation; Survival Rate; Tacrolimus; Tissue Donors | 1991 |
Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion.
Topics: Animals; Azathioprine; Bone Marrow Transplantation; Cyclosporins; Dogs; Female; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphatic System; Male; Pyridines; Skin Transplantation; Tacrolimus; Transplantation, Homologous | 1989 |
Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay.
Topics: Azathioprine; Cells, Cultured; Colony-Forming Units Assay; Cyclosporins; Drug Therapy, Combination; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Monocytes; Prednisolone; Pyridines; Ribonucleosides; Tacrolimus; Transplantation, Homologous | 1989 |
Liver transplantation: an unfinished product.
Topics: Animals; Azathioprine; Cyclosporins; Graft Survival; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Pyridines; Tacrolimus; Tissue Preservation | 1989 |
Augmentation of hepatocyte proliferation by immunosuppressant pretherapy is associated with up-regulation of malondialdehyde production.
Topics: Animals; Azathioprine; Cell Division; Cyclosporine; DNA; DNA Replication; Female; Lipid Peroxidation; Liver; Liver Regeneration; Malondialdehyde; Premedication; Rats; Rats, Sprague-Dawley; Tacrolimus; Thiobarbituric Acid Reactive Substances; Up-Regulation | 1993 |
The effect of immunosuppressants on human leukocyte NADPH oxidase.
Topics: Antigen-Presenting Cells; Azathioprine; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Monocytes; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Polyenes; Sirolimus; Tacrolimus | 1994 |
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.
Topics: Animals; Azathioprine; Drug Synergism; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Lethal Dose 50; Male; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Homologous | 1994 |
Living donor kidney transplantation in Japan.
Topics: Adult; Azathioprine; Blood Group Incompatibility; Child; Cyclosporine; Drug Therapy, Combination; Family; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Retrospective Studies; Ribonucleosides; Survival Rate; Tacrolimus; Time Factors; Tissue Donors | 1994 |
Intensive care after orthotopic liver transplantation.
Topics: Adolescent; Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Blood Loss, Surgical; Child; Child, Preschool; Critical Care; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Period; Regression Analysis; Respiration, Artificial; Retrospective Studies; Serum Albumin; Tacrolimus | 1994 |
[Rejection of a liver allograft. Diagnosis and treatment].
Topics: Acute Disease; Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Liver Transplantation; Postoperative Complications; Tacrolimus; Transplantation, Homologous | 1994 |
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Administration Schedule; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppression Therapy; Liver Failure; Liver Transplantation; Postoperative Complications; Prednisolone; Receptors, Interleukin-2; Recurrence; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 1994 |
Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Prednisolone; Prednisone; Survival Rate; Tacrolimus | 1995 |
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
Topics: Animals; Azathioprine; Drug Synergism; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Homologous | 1995 |
Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C.
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Graft Survival; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Kidney Transplantation; Pilot Projects; Retrospective Studies; Tacrolimus; Time Factors | 1995 |
Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
Topics: Adolescent; Adult; Antihypertensive Agents; Azathioprine; Cardiac Catheterization; Child; Cyclosporine; Drug Therapy, Combination; Echocardiography; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppression Therapy; Kidney Diseases; Lymphoproliferative Disorders; Prednisone; Tacrolimus; Time Factors | 1995 |
FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Topics: Adult; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Methylprednisolone Hemisuccinate; Middle Aged; Muromonab-CD3; Risk Factors; Tacrolimus; Time Factors | 1995 |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
Topics: Animals; Antibodies; Antineoplastic Agents; Azathioprine; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Methotrexate; Mycophenolic Acid; Rats; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Heterologous | 1993 |
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.
Topics: Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies; Steroids; Tacrolimus | 1993 |
FK 506 in the management of nephrotic syndrome after renal transplantation.
Topics: Azathioprine; Biopsy; Creatinine; Cyclosporine; Graft Rejection; Humans; Kidney Transplantation; Nephrotic Syndrome; Pilot Projects; Postoperative Complications; Prednisone; Proteinuria; Tacrolimus; Transplantation, Homologous | 1993 |
Rejection: FK 506 for rescue or maintenance.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Liver Transplantation; Middle Aged; Retrospective Studies; Steroids; Tacrolimus; Time Factors | 1993 |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Topics: Adrenal Cortex Hormones; Alanine Transaminase; Azathioprine; Bilirubin; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Liver Transplantation; Methylprednisolone; Prednisone; Recurrence; Tacrolimus; Transplantation, Homologous | 1993 |
FK 506 rescue therapy: early conversion improves efficacy.
Topics: ABO Blood-Group System; Adrenal Cortex Hormones; Alanine Transaminase; Azathioprine; Bilirubin; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Liver Transplantation; Tacrolimus; Time Factors; Transplantation, Homologous | 1993 |
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Alanine Transaminase; Azathioprine; Bilirubin; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppression Therapy; Liver Function Tests; Liver Transplantation; Muromonab-CD3; Prednisone; Tacrolimus; Time Factors; Transplantation, Homologous | 1993 |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
Topics: Adult; Azathioprine; Black People; Blood Glucose; Diabetes Mellitus; Drug Therapy, Combination; Female; Humans; Incidence; Kidney Transplantation; Male; Prednisone; Tacrolimus | 1993 |
FK 506-based immunosuppression in clinical pancreas transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Pancreas Transplantation; Tacrolimus | 1995 |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Topics: Acute Disease; Adult; Azathioprine; Biopsy; Blood Glucose; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Prednisone; Tacrolimus; Transplantation, Homologous | 1996 |
Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Retrospective Studies; Ribonucleosides; Tacrolimus; Time Factors | 1996 |
Reduction of immunosuppressive agents after living related donor liver transplantation.
Topics: ABO Blood-Group System; Azathioprine; Blood Grouping and Crossmatching; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Fathers; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Mothers; Prednisolone; Retrospective Studies; Tacrolimus; Time Factors; Tissue Donors | 1996 |
Lung transplantation in infancy and early childhood.
Topics: Actuarial Analysis; Azathioprine; Cause of Death; Cyclosporine; Graft Rejection; Heart Defects, Congenital; Humans; Immunosuppressive Agents; Infant; Lung Diseases; Lung Transplantation; Prednisone; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome; Virus Diseases | 1996 |
Orthotopic liver-small bowel transplantation in pigs: study of immunologic parameters during therapy with FK 506-based immunosuppressive regimens.
Topics: Animals; Azathioprine; Cells, Cultured; Cytotoxicity, Immunologic; Drug Therapy, Combination; Graft Survival; Histocompatibility Testing; Immunosuppressive Agents; Intestine, Small; Liver Transplantation; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Steroids; Swine; Tacrolimus; Transplantation, Homologous | 1996 |
Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Immunosuppressive Agents; Intestine, Small; Liver Transplantation; Postoperative Complications; Steroids; Swine; Tacrolimus; Transplantation, Homologous | 1996 |
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Methylprednisolone Hemisuccinate; Prednisone; Tacrolimus; Time Factors; Treatment Failure | 1996 |
Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.
Topics: Adult; Azathioprine; Blood Glucose; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Steroids; Tacrolimus | 1996 |
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
Topics: Azathioprine; Chromatography, Liquid; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Transplantation; Mass Spectrometry; Regression Analysis; Tacrolimus | 1996 |
Weaning of immunosuppression in liver transplant recipients.
Topics: Adult; Analysis of Variance; Azathioprine; Child; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Liver Function Tests; Liver Transplantation; Postoperative Complications; Prednisone; Pregnancy; Prospective Studies; Retrospective Studies; Tacrolimus; Time Factors | 1997 |
Small bowel transplantation under oral immunosuppression: experimental study in the pig.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Immunosuppressive Agents; Intestine, Small; Parenteral Nutrition, Total; Prednisone; Swine; Tacrolimus; Time Factors; Transplantation, Homologous | 1997 |
Combined orthotopic liver-small bowel transplantation or small bowel transplantation in pigs: relations between survival, rejection, and mucosal morphometry.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Immunosuppressive Agents; Intestinal Mucosa; Intestine, Small; Liver Transplantation; Prednisone; Swine; Tacrolimus | 1997 |
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Ganciclovir; Glucocorticoids; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Incidence; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Muromonab-CD3; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Tumor Virus Infections | 1997 |
Reversal of accelerated renal allograft rejection with FK 506.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies; Antilymphocyte Serum; Azathioprine; Biopsy; Cadaver; Capillaries; Complement C3; Creatinine; Cyclosporine; Fibrin; Glucocorticoids; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Male; Methylprednisolone Hemisuccinate; Neutrophils; Reoperation; Tacrolimus; Urinary Retention | 1997 |
Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients.
Topics: Adult; Age Factors; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Azathioprine; Bacterial Proteins; Cephalosporins; Chi-Square Distribution; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin G; Immunosuppressive Agents; Liver Transplantation; Male; Penicillins; Prednisone; Prevalence; Seroepidemiologic Studies; Sex Factors; Tacrolimus; Time Factors | 1997 |
Maintenance pharmacological immunosuppressive strategies in renal transplantation.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Polyenes; Postoperative Care; Sirolimus; Steroids; Tacrolimus | 1997 |
The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
Topics: Administration, Oral; Age Factors; Aged; Azathioprine; Cadaver; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Tacrolimus; Treatment Outcome | 1997 |
[A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
Topics: Adult; Azathioprine; Drug Administration Schedule; Female; Glomerulonephritis, IGA; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisolone; Recurrence; Tacrolimus | 1997 |
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
Topics: Azathioprine; Black or African American; Black People; Cadaver; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Mycophenolic Acid; Philadelphia; Retrospective Studies; Tacrolimus; Tissue Donors; White People | 1997 |
Combination therapy of tacrolimus (FK506) with azathioprine and steroids in renal transplant recipients.
Topics: Azathioprine; Drug Therapy, Combination; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisone; Tacrolimus | 1998 |
Epstein-Barr virus infections in children after transplantation of the small intestine.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Female; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Infant; Intestine, Small; Lymphoproliferative Disorders; Male; Tacrolimus; Transplantation, Homologous; Tumor Virus Infections | 1998 |
Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats.
Topics: Animals; Azathioprine; Cyclosporine; Drug Evaluation, Preclinical; Immunosuppressive Agents; Interleukin-16; Liver; Male; Neutrophils; Polyenes; Rats; Rats, Wistar; Reperfusion Injury; Sirolimus; Tacrolimus; Time Factors | 1998 |
Impact of immunosuppression on coronary endothelial function after cardiac transplantation.
Topics: Azathioprine; Coronary Vessels; Cyclosporine; Drug Therapy, Combination; Endothelium, Vascular; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Microcirculation; Prednisone; Tacrolimus; Time Factors | 1998 |
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Hyperglycemia; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Medical Records; Prednisone; Retrospective Studies; Tacrolimus | 1998 |
Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Graft Rejection; Heart Function Tests; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Muromonab-CD3; Postoperative Complications; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 1998 |
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Retrospective Studies; Tacrolimus | 1998 |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Topics: ABO Blood-Group System; Adolescent; Adult; Azathioprine; Blood Group Incompatibility; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1998 |
Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
Topics: Adult; Aged; Azathioprine; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lipids; Middle Aged; Prednisolone; Tacrolimus; Triglycerides | 1998 |
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients.
Topics: Adult; Azathioprine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Muromonab-CD3; Prednisolone; Retrospective Studies; Steroids; Tacrolimus | 1998 |
Influence of early FK 506 trough levels on glomerular hemodynamics at 3 months in kidney transplant recipients.
Topics: Adult; Aldosterone; Amino Acids; Azathioprine; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemodynamics; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Transplantation; Male; Prednisone; Propranolol; Renal Circulation; Renin; Tacrolimus; Time Factors; Vascular Resistance | 1998 |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
Topics: Administration, Oral; Adult; Azathioprine; Communicable Diseases; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Muromonab-CD3; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
FK506 for primary and rescue therapy following liver transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Muromonab-CD3; Prednisolone; Retrospective Studies; Survival Rate; Tacrolimus | 1998 |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases.
Topics: Acute Disease; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Tacrolimus | 1998 |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Prednisone; Recurrence; Reoperation; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation.
Topics: Adult; Azathioprine; Brain Diseases; Cyclosporine; Demyelinating Diseases; Drug Therapy, Combination; Family; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Living Donors; Magnetic Resonance Imaging; Middle Aged; Prednisolone; Syndrome; Tacrolimus; Tomography, X-Ray Computed | 1998 |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Medical Records; Methylprednisolone; Middle Aged; Retrospective Studies; Survival Rate; Tacrolimus | 1998 |
Late acute rejection episodes after vascularized pancreas transplantation.
Topics: Acute Disease; Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Pancreas Transplantation; Prednisone; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Mycophenolate mofetil in pancreas transplantation.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Survival Rate; Tacrolimus | 1998 |
Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
Topics: Azathioprine; Biliary Atresia; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Emulsions; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Methylprednisolone; Tacrolimus | 1998 |
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Tacrolimus | 1998 |
Combined liver-kidney transplantation: long-term follow-up in 18 patients.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prednisolone; Reoperation; Survival Rate; Tacrolimus; Time Factors | 1998 |
Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
Topics: Adrenal Cortex Hormones; Antibody Formation; Azathioprine; Biopsy; Complement C4; Complement C4b; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Peptide Fragments; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Tubular damage and impairment of renal function in transplanted kidneys.
Topics: Acetylglucosaminidase; Adult; Aged; Albuminuria; Azathioprine; Biomarkers; Creatinine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubules; L-Lactate Dehydrogenase; Male; Middle Aged; Mycophenolic Acid; Prednisone; Regional Blood Flow; Renal Circulation; Tacrolimus | 1998 |
Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients.
Topics: Adrenal Cortex Hormones; Antioxidants; Azathioprine; Cholesterol; Creatine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Kinetics; Lipoproteins, LDL; Male; Middle Aged; Tacrolimus; Triglycerides; Urea | 1998 |
Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function.
Topics: Adult; Azathioprine; Cyclosporine; Databases as Topic; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Tacrolimus | 1998 |
Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation?
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors; Vasoconstriction; Vasodilation | 1998 |
Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation.
Topics: Azathioprine; Bronchoscopy; Creatinine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Lung Transplantation; Outcome Assessment, Health Care; Prednisone; Retrospective Studies; Tacrolimus | 1998 |
Graft-versus-host reaction and graft rejection after liver, small bowel or small bowel allotransplantation in the pig.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Graft vs Host Reaction; Immunosuppressive Agents; Intestine, Small; Liver Transplantation; Prednisone; Skin; Swine; Tacrolimus; Transplantation, Homologous | 1998 |
Low level of interleukin 10 synthesis during liver allograft rejection.
Topics: Acute Disease; Azathioprine; Cells, Cultured; Chronic Disease; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-10; Liver Transplantation; Lymphocyte Culture Test, Mixed; Lymphocytes; Methylprednisolone; Tacrolimus; Transplantation, Homologous | 1998 |
Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Hong Kong; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1998 |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan.
Topics: Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Steroids; Tacrolimus; Taiwan; Transplantation, Homologous | 1998 |
FK506 "rescue" therapy complicated by renal tubular acidosis in renal allograft recipients.
Topics: Acidosis, Renal Tubular; Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Prednisolone; Tacrolimus; Transplantation, Homologous | 1998 |
Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Muromonab-CD3; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
[Liver transplantation: experiences and results of a program at the University of Liege].
Topics: Actuarial Analysis; Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Belgium; Chronic Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Diseases; Liver Transplantation; Myocardial Infarction; Postoperative Complications; Reoperation; Survival Rate; Tacrolimus; Time Factors; Waiting Lists | 1998 |
Outcome of twin pregnancy in a renal transplant recipient treated with tacrolimus.
Topics: Azathioprine; Cesarean Section; Cyclosporine; Fatal Outcome; Female; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Infant, Newborn; Infant, Premature; Kidney Transplantation; Labetalol; Living Donors; Male; Nuclear Family; Prednisone; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Tacrolimus; Twins | 1999 |
Long-term results of pancreas transplantation under tacrolius immunosuppression.
Topics: Actuarial Analysis; Adult; Antilymphocyte Serum; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Mycophenolic Acid; Pancreas Transplantation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 1999 |
Pediatric renal transplantation under tacrolimus-based immunosuppression.
Topics: Actuarial Analysis; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Child; Child, Preschool; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Kidney Transplantation; Postoperative Complications; Reoperation; Retrospective Studies; Survival Analysis; Tacrolimus; Tissue Donors | 1999 |
Optimization of the immunosuppressive protocol after lung transplantation.
Topics: Acute Disease; Adult; Animals; Antilymphocyte Serum; Azathioprine; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Rabbits; Retrospective Studies; Tacrolimus | 1999 |
Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
Topics: Aged; Azathioprine; Biopsy; Blood Pressure; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lipids; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Renal Insufficiency; Retrospective Studies; Tacrolimus; Treatment Outcome; Urea | 1999 |
Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Azathioprine; Clarithromycin; Creatinine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Prednisone; Tacrolimus | 1999 |
The effect of different immunosuppression on the outcome of pediatric renal transplants.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Tacrolimus | 1999 |
Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression.
Topics: ABO Blood-Group System; Adult; Azathioprine; Blood Group Incompatibility; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Tacrolimus; Treatment Failure; Treatment Outcome | 1999 |
Two cases of tacrolimus-induced alopecia following kidney transplantation.
Topics: Adult; Alopecia; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Prednisolone; Tacrolimus | 1999 |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine.
Topics: Analysis of Variance; Azathioprine; Cyclosporine; Gastric Emptying; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Reference Values; Tacrolimus | 1999 |
Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia.
Topics: Adult; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Eosinophilia; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukocyte Count; Male; Middle Aged; Pneumonia, Pneumocystis; Prednisolone; Retrospective Studies; Tacrolimus | 1999 |
A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
Topics: Animals; Azathioprine; Cell Division; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; In Vitro Techniques; Islets of Langerhans Transplantation; Leukocytes, Mononuclear; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Methylprednisolone; Mycophenolic Acid; Phytohemagglutinins; Sirolimus; Species Specificity; Swine; Tacrolimus; Transplantation, Homologous | 1999 |
[Combined renal and pancreas transplantation as treatment for chronic renal insufficiency of diabetic origin: a series of 50 consecutive transplantations].
Topics: Adult; Azathioprine; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Survival Analysis; Tacrolimus; Treatment Outcome | 1999 |
Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes.
Topics: Antigens, CD; Azathioprine; Cell Differentiation; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Subsets; Lymphocytes; Mycophenolic Acid; Tacrolimus | 2000 |
Tacrolimus in corticosteroid-resistant ulcerative colitis.
Topics: Aged; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Leukapheresis; Methylprednisolone; Prednisolone; Remission Induction; Sulfasalazine; Tacrolimus; Treatment Failure | 2000 |
Local immunosuppression in clinical small bowel transplantation (report of two cases).
Topics: Adolescent; Azathioprine; Colon; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Intestine, Small; Male; Methylprednisolone; Reoperation; Tacrolimus; Tissue and Organ Harvesting; Transplantation, Homologous; Treatment Outcome | 2000 |
Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Recurrence; Retrospective Studies; Ribonucleosides; Survival Rate; Tacrolimus; Time Factors | 2000 |
Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Retrospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome | 2000 |
Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
Topics: Adult; Azathioprine; Cholesterol; Cholesterol, HDL; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; Japan; Kidney Transplantation; Male; Methylprednisolone; Postoperative Complications; Retrospective Studies; Ribonucleosides; Risk Factors; Tacrolimus; Triglycerides | 2000 |
Risk factors of acute tacrolimus nephrotoxicity in renal allografts.
Topics: ABO Blood-Group System; Adult; Age Factors; Azathioprine; Blood Group Incompatibility; Creatinine; Diabetes Mellitus; Drug Therapy, Combination; Female; Histocompatibility Testing; HLA-DR Antigens; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Methylprednisolone; Middle Aged; Risk Factors; Tacrolimus; Tissue Donors; Transplantation, Homologous | 2000 |
Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
Topics: Adult; Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Tacrolimus | 2000 |
Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
Topics: Adult; Apolipoprotein C-III; Apolipoproteins A; Apolipoproteins B; Apolipoproteins C; Azathioprine; Calcineurin Inhibitors; Cholesterol; Cyclosporine; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Reference Values; Sirolimus; Tacrolimus; Triglycerides | 2000 |
Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients.
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Cholesterol; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Tacrolimus; Triglycerides | 2000 |
Conversion from tacrolimus to neoral for postrenal transplant diabetes.
Topics: Adrenal Cortex Hormones; Azathioprine; Child; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus | 2000 |
Immunodepressants ameliorate normothermic ischemia injury to the rat liver by down-regulating tumor necrosis factor, not by alleviation of lipid peroxidative injury.
Topics: Alanine Transaminase; Animals; Azathioprine; Cyclosporine; Female; Immunosuppressive Agents; Ischemia; Lipid Peroxidation; Liver; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tacrolimus; Temperature; Time Factors; Tumor Necrosis Factor-alpha | 1994 |
Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
Topics: Absorptiometry, Photon; Azathioprine; Bone Density; Cyclosporine; Drug Therapy, Combination; Femur Neck; Humans; Immunosuppressive Agents; Liver Transplantation; Lumbar Vertebrae; Male; Osteoporosis; Parathyroid Hormone; Postoperative Complications; Prednisone; Prospective Studies; Tacrolimus; Vitamin D | 2001 |
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
Topics: Adult; Azathioprine; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Hyperlipidemias; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Prednisolone; Retrospective Studies; Steroids; Tacrolimus; Time Factors | 2001 |
Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Prednisolone; Receptors, Interleukin-2; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 2001 |
Tolerability of mycophenolate mofetil in organ transplant recipients.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Medical Records; Mycophenolic Acid; Prednisone; Retrospective Studies; Tacrolimus | 2001 |
Immunocompetence assay for net effect of combined immunosuppression.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunocompetence; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mycophenolic Acid; Tacrolimus | 2001 |
Pharmacokinetics of tacrolimus during the early phase after heart transplantation.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Body Weight; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Postoperative Period; Regression Analysis; Tacrolimus; Time Factors | 2001 |
Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation.
Topics: Azathioprine; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Mycophenolic Acid; Patient Selection; Research Design; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2001 |
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Male; Postoperative Complications; Prednisone; Retrospective Studies; Tacrolimus | 2001 |
Prevalence and causes of low bone density and fractures in kidney transplant patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Back Pain; Biomarkers; Bone Density; Cyclosporine; Female; Fractures, Bone; Humans; Kidney Transplantation; Male; Middle Aged; Prednisolone; Prevalence; Tacrolimus; United Kingdom | 2001 |
Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients.
Topics: Adult; Azathioprine; Brachial Artery; Calcineurin Inhibitors; Carotid Artery, Common; Cyclosporine; Elasticity; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muscles; Nephrectomy; Postoperative Period; Reference Values; Sympathetic Nervous System; Tacrolimus; Vasomotor System | 2002 |
Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Topics: Adolescent; Adult; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Autoantibodies; Autoantigens; Azathioprine; Blotting, Western; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Epitopes; Female; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Isoenzymes; Kidney Diseases; Kidney Transplantation; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Mixed Function Oxygenases; Postoperative Complications; Prednisone; Recombinant Fusion Proteins; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tacrolimus | 2002 |
Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.
Topics: Antibodies; Antilymphocyte Serum; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Liver Transplantation; Postoperative Complications; Prednisone; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors | 2002 |
Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Azathioprine; Blood Glucose; Blood Pressure; Cholesterol; Creatinine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Retrospective Studies; Safety; Tacrolimus | 2002 |
Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy.
Topics: Adolescent; Adult; Aged; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors; Transplantation, Homologous | 2002 |
Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center.
Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Heart Arrest; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Renal Replacement Therapy; Retrospective Studies; Tacrolimus; Time Factors; Tissue Donors; Waiting Lists | 2002 |
Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pancreas Transplantation; Prednisolone; Prednisone; Tacrolimus; Time Factors; Treatment Failure; Treatment Outcome | 2002 |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation.
Topics: Adolescent; Antilymphocyte Serum; Azathioprine; Body Weight; Cadaver; California; Child; Cyclosporine; Drug Therapy, Combination; Female; Humans; Kidney Transplantation; Living Donors; Male; Medical Records; Mycophenolic Acid; Racial Groups; Retrospective Studies; Tacrolimus; Tissue Donors | 2002 |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2002 |
Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcineurin Inhibitors; Child; Creatinine; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Renal Insufficiency; Tacrolimus | 2002 |
Effect of low-dose calcineurin inhibitors on acute rejection and graft survival.
Topics: Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Retrospective Studies; Tacrolimus | 2002 |
[Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
Topics: Adult; Antihypertensive Agents; Apolipoproteins B; Arteriosclerosis; Azathioprine; Cholesterol; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Prednisone; Retrospective Studies; Tacrolimus; Triglycerides | 2002 |
Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience.
Topics: Abnormalities, Drug-Induced; Adult; Azathioprine; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infant, Newborn; Kidney Transplantation; Logistic Models; Prednisone; Pregnancy; Pregnancy Outcome; Tacrolimus; Teratogens | 2003 |
Effects of selected immunouppressive drugs on prostaglandin release, protein synthesis and cell proliferation in human gingival fibroblasts and on the growth of plaque bacteria.
Topics: Actinomyces viscosus; Aggregatibacter actinomycetemcomitans; Azathioprine; Capnocytophaga; Cell Division; Cells, Cultured; Cyclosporine; Dental Plaque; Dinoprostone; Fibroblasts; Gingiva; Humans; Immunosuppressive Agents; Mycophenolic Acid; Peptostreptococcus; Protein Biosynthesis; Streptococcus mutans; Tacrolimus | 2003 |
Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study.
Topics: Adult; Aged; Azathioprine; Depression; Drug Therapy, Combination; Female; Health Status; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Period; Quality of Life; Self Concept; Sex Characteristics; Steroids; Tacrolimus | 2003 |
Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.
Topics: Azathioprine; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Databases, Factual; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Tacrolimus | 2003 |
Steroid-free immunosuppression during and after liver transplantation--a 3-yr follow-up report.
Topics: Azathioprine; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Methylprednisolone Hemisuccinate; Middle Aged; Pilot Projects; Prospective Studies; Tacrolimus; Time Factors | 2003 |
De novo tumors after kidney transplantation: the Budapest experience.
Topics: Azathioprine; Cyclosporine; Female; Humans; Hungary; Immunosuppressive Agents; Kidney Transplantation; Neoplasms; Postoperative Complications; Prednisolone; Retrospective Studies; Risk Factors; Tacrolimus | 2003 |
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Tacrolimus | 2003 |
A comparison of discharge immunosuppressive drug regimens in primary cadaveric kidney transplantation.
Topics: Adolescent; Azathioprine; Cadaver; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Tacrolimus; Treatment Outcome | 2003 |
Clinical pharmacokinetics of tacrolimus in heart transplantation: new strategies of monitoring.
Topics: Adult; Area Under Curve; Azathioprine; Drug Monitoring; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Metabolic Clearance Rate; Middle Aged; Tacrolimus | 2003 |
High incidence of severe infections in heart transplant recipients receiving tacrolimus.
Topics: Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Infections; Male; Middle Aged; Postoperative Complications; Prednisone; Retrospective Studies; Tacrolimus | 2003 |
Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients.
Topics: Azathioprine; Cadaver; Creatinine; Drug Therapy, Combination; Follow-Up Studies; Histocompatibility Testing; Humans; Immunosuppressive Agents; Isoantibodies; Japan; Kidney Transplantation; Living Donors; Postoperative Complications; Prednisolone; Tacrolimus; Time Factors; Tissue Donors | 1992 |
Neuroprotective effects of FK-506, L-carnitine and azathioprine on spinal cord ischemia-reperfusion injury.
Topics: Animals; Azathioprine; Carnitine; Drug Therapy, Combination; Immunohistochemistry; Immunosuppressive Agents; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spinal Cord Ischemia; Tacrolimus | 2004 |
Effect of Anapsos in a murine model of experimental trichomoniasis.
Topics: Adjuvants, Immunologic; Animals; Azathioprine; Cyclophosphamide; Disease Models, Animal; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Glycosides; Humans; Immunosuppressive Agents; Male; Mice; Plant Extracts; Polypodium; Random Allocation; Tacrolimus; Trichomonas Infections; Trichomonas vaginalis; Trichomonas Vaginitis | 2003 |
The effect of maintenance immunosuppression medication on the change in kidney allograft function.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Databases, Factual; Female; Glomerular Filtration Rate; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2004 |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.
Topics: Adult; Aged; Azathioprine; Bronchi; Bronchiolitis Obliterans; Cell Division; Cells, Cultured; Cyclosporine; Everolimus; Female; Fibroblasts; Humans; Immunosuppressive Agents; Infections; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Tacrolimus | 2004 |
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression.
Topics: Administration, Oral; Adolescent; Anticholesteremic Agents; Area Under Curve; Azathioprine; Calcineurin Inhibitors; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Drug Interactions; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Mycophenolic Acid; Pravastatin; Tacrolimus; Triglycerides | 2004 |
Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus.
Topics: Adolescent; Adult; Aged; Azathioprine; Calcium Channel Blockers; Chi-Square Distribution; Cyclosporine; Drug Interactions; Female; Gingival Overgrowth; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Prednisolone; Regression Analysis; Risk Factors; Statistics, Nonparametric; Tacrolimus | 2004 |
The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation.
Topics: Adolescent; Age Factors; Azathioprine; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Enzyme Inhibitors; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Infant; Kidney; Liver Transplantation; Male; Matched-Pair Analysis; Retrospective Studies; Statistics, Nonparametric; Survival Rate; Tacrolimus | 2004 |
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
Topics: Acute Disease; Adult; Australia; Azathioprine; Bronchiolitis Obliterans; Canada; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; Forced Expiratory Volume; Graft Rejection; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Incidence; Kidney; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2004 |
About the neuroprotective effects of FK-506, l-carnitine and azathioprine on spinal cord ischemia-reperfusion injury.
Topics: Animals; Azathioprine; Carnitine; Neuroprotective Agents; Rats; Reperfusion Injury; Spinal Cord Ischemia; Tacrolimus | 2004 |
Current immunosuppressive agents in pediatric renal transplantation: efficacy, side-effects and utilization.
Topics: Acute Disease; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Daclizumab; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Muromonab-CD3; Mycophenolic Acid; Sirolimus; Tacrolimus; Treatment Outcome | 2004 |
[Clinical results of immunosuppressive triple therapies in living-related renal transplantation--a single center experience].
Topics: Adult; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Tacrolimus; Treatment Outcome | 2004 |
Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis.
Topics: Adolescent; Azathioprine; Child; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Monitoring, Physiologic; Recurrence; Retrospective Studies; Tacrolimus; Thioguanine | 2004 |
Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient.
Topics: Area Under Curve; Azathioprine; Clarithromycin; Drug Administration Schedule; Drug Interactions; Duodenitis; Half-Life; Heart Transplantation; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Tacrolimus | 2005 |
Tuberculosis in renal transplant recipients on various immunosuppressive regimens.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisolone; Retrospective Studies; Tacrolimus; Tuberculosis | 2005 |
Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
Topics: Antibody Formation; Azathioprine; Blood Transfusion; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; HLA Antigens; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Reoperation; Steroids; Tacrolimus | 2005 |
Airway cellular response to two different immunosuppressive regimens in lung transplant recipients.
Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Bronchoalveolar Lavage Fluid; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Clinical Protocols; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphocytes; Male; Methylprednisolone; Middle Aged; Receptors, Interleukin-2; Recombinant Fusion Proteins; Retrospective Studies; T-Lymphocytes; Tacrolimus; Transplantation Conditioning | 2005 |
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
Topics: Adult; Age Factors; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Recurrence; Tacrolimus | 2005 |
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen.
Topics: Adoptive Transfer; Animals; Azathioprine; CD4-Positive T-Lymphocytes; Cyclosporine; Dendritic Cells; Graft Survival; Immunosuppression Therapy; Immunosuppressive Agents; Interleukin-2; Isoantigens; Mice; Mycophenolic Acid; Sirolimus; Spleen; Tacrolimus; Time Factors; Tissue Donors; Trachea; Transplantation | 2005 |
Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression.
Topics: Azathioprine; Costs and Cost Analysis; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Spain; Tacrolimus; Time Factors | 2005 |
Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin).
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Azathioprine; Child; Child, Preschool; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Infant; Intestinal Diseases; Intestines; Lymphocyte Depletion; Male; Prednisone; Rabbits; Tacrolimus | 2005 |
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
Topics: Area Under Curve; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisolone; Tacrolimus | 2005 |
Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Basiliximab; Body Mass Index; Case-Control Studies; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Muromonab-CD3; Mycophenolic Acid; Pilot Projects; Recombinant Fusion Proteins; Retrospective Studies; Steroids; Survival Rate; Tacrolimus | 2005 |
High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies.
Topics: Alkylating Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites; Azathioprine; Cyclophosphamide; Drug Resistance; Female; Humans; Immunization, Passive; Immunosuppressive Agents; Middle Aged; Muscle, Skeletal; Myasthenia Gravis; Plasma Exchange; Prednisone; Protein-Tyrosine Kinases; Rituximab; Tacrolimus | 2006 |
The role of immunosuppressive drugs in transplantation.
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Muromonab-CD3; Mycophenolic Acid; Tacrolimus; Transplantation Immunology | 1998 |
Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus.
Topics: Adiponectin; Adult; Azathioprine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2; Female; Genes, MDR; Humans; Immunosuppressive Agents; Incidence; Ion Channels; Kidney Transplantation; Male; Membrane Transport Proteins; Middle Aged; Mitochondrial Proteins; Multivariate Analysis; Mycophenolic Acid; Peptidyl-Dipeptidase A; Polymorphism, Genetic; PPAR gamma; Receptors, Calcitriol; Risk Factors; Tacrolimus; Uncoupling Protein 2 | 2005 |
Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function.
Topics: Adult; Azathioprine; Biopsy; Calcineurin Inhibitors; Creatinine; Cyclosporine; Delayed Graft Function; Drug Administration Schedule; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; Risk Factors; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2006 |
[Inhibition of phosphatidylethanolamine and phosphatidylinositol synthesis, alteration of the G0 and G1 cell cycle phases and spontaneous apoptosis in lymphocytes from patients under immunosuppressive treatment].
Topics: Apoptosis; Azathioprine; Cells, Cultured; Concanavalin A; Culture Media; Flow Cytometry; G1 Phase; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Membrane Lipids; Mycophenolic Acid; Phosphatidylethanolamines; Phosphatidylinositols; Resting Phase, Cell Cycle; S Phase; Tacrolimus | 2005 |
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
Topics: Adult; Aged; Azathioprine; Colectomy; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Pouchitis; Remission Induction; Retrospective Studies; Steroids; Tacrolimus; Treatment Outcome | 2006 |
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure | 2007 |
Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Creatinine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Prednisone; Steroids; Tacrolimus; Time Factors | 2006 |
[Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs].
Topics: Azathioprine; Cyclosporine; DNA Repair; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Neoplasms; Tacrolimus; Transplantation | 2005 |
Tumor lysis syndrome associated with reduced immunosuppression in a lung transplant recipient.
Topics: Aged; Azathioprine; Fatal Outcome; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Male; Substance Withdrawal Syndrome; Tacrolimus; Tumor Lysis Syndrome | 2006 |
Effect of immunoadsorption on refractory idiopathic focal and segmental glomerulosclerosis.
Topics: Adult; Anemia, Megaloblastic; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Blood Proteins; Combined Modality Therapy; Cyclophosphamide; Drug Resistance; Glomerulosclerosis, Focal Segmental; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephrotic Syndrome; Plasmapheresis; Proteinuria; Sepharose; Staphylococcal Protein A; Tacrolimus | 2006 |
Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Azathioprine; Bronchiolitis Obliterans; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Female; Forkhead Transcription Factors; Gene Expression; Graft Rejection; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Lung Transplantation; Lymphocyte Activation; Lymphocyte Subsets; Male; Middle Aged; Mycophenolic Acid; Steroids; T-Lymphocytes, Regulatory; Tacrolimus | 2006 |
Autoimmune hepatitis: are we using the right therapy?
Topics: Adolescent; Animals; Azathioprine; Child; Cyclosporine; Disease Models, Animal; Genetic Predisposition to Disease; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mice; Tacrolimus | 2007 |
Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
Topics: ABO Blood-Group System; Azathioprine; Blood Grouping and Crossmatching; Cyclosporine; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Methylprednisolone; Mycophenolic Acid; Tacrolimus; Time Factors; Treatment Outcome | 2007 |
Risk factors for malignancy in Japanese renal transplant recipients.
Topics: Adult; Age Factors; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Japan; Kidney Transplantation; Male; Neoplasms; Risk Factors; Survival Rate; Tacrolimus | 2007 |
Incidence of tacrolimus-induced gingival overgrowth in the absence of calcium channel blockers: a short-term study.
Topics: Adult; Anti-Infective Agents; Azathioprine; Calcium Channel Blockers; Cyclosporine; Dental Plaque Index; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Overgrowth; Gingival Recession; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Periodontal Index; Periodontal Pocket; Tacrolimus; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Tacrolimus (Pan Graf) in live related renal transplantation: an initial experience of 101 recipients in India.
Topics: Adolescent; Adult; Azathioprine; Child; Drug Therapy, Combination; Family; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Tacrolimus | 2007 |
[Clinical application and side effects of immunosuppressant].
Topics: Adjuvants, Immunologic; Azathioprine; Cyclosporine; Glucocorticoids; Humans; Mycophenolic Acid; Tacrolimus | 2007 |
Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome; Uveitis | 2007 |
Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Topics: Azathioprine; Cyclosporine; Enzyme Inhibitors; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Neoplasms; Postoperative Complications; Protein Kinases; Risk; Risk Factors; Tacrolimus; TOR Serine-Threonine Kinases | 2007 |
The patient with persistent perianal fistulae.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Humans; Infliximab; Magnetic Resonance Imaging; Mercaptopurine; Rectal Fistula; Tacrolimus; Treatment Outcome | 2007 |
Role of maintenance immunosuppressive regimen in kidney transplant outcome.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome | 2006 |
Posttransplantation conversion to sirolimus-based immunosuppression: a single center experience.
Topics: Azathioprine; Drug Therapy, Combination; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Sirolimus; Tacrolimus; Treatment Outcome | 2007 |
Gingival overgrowth in renal transplant subjects medicated with tacrolimus in the absence of calcium channel blockers.
Topics: Adult; Aged; Azathioprine; Calcium Channel Blockers; Chi-Square Distribution; Dental Plaque; Female; Gingiva; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisolone; Regression Analysis; Retrospective Studies; Tacrolimus; Time Factors | 2008 |
Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor.
Topics: Area Under Curve; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Antagonism; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Sirolimus; Tacrolimus | 2008 |
Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
Topics: Administration, Oral; Adult; Antibodies; Antimetabolites; Australia; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; New Zealand; Practice Patterns, Physicians'; Prednisolone; Protein Kinases; Registries; Sirolimus; Steroids; Tacrolimus; Time Factors; TOR Serine-Threonine Kinases | 2008 |
Audiometric changes in patients undergoing liver transplantation using distinct immunosuppressive protocols.
Topics: Adolescent; Adult; Aged; Audiometry; Azathioprine; Cyclosporine; Female; Functional Laterality; Hearing; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Prednisone; Retrospective Studies; Tacrolimus | 2008 |
Glucose and leucine metabolism in lung tranplanted patients on low dose of steroids for immunosuppressive therapy.
Topics: Adult; Aged; Azathioprine; Blood Glucose; Cyclosporine; Fatty Acids, Nonesterified; Female; Glucocorticoids; Hormones; Humans; Immunosuppressive Agents; Insulin Resistance; Leucine; Lung Transplantation; Male; Middle Aged; Prednisone; Tacrolimus | 2008 |
Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Cyclosporine; Desmoglein 3; Dexamethasone; Disease Models, Animal; Disease Progression; Female; Immunoglobulin G; Immunosuppressive Agents; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Mice, Knockout; Pemphigus; Phenotype; Tacrolimus | 2009 |
Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
Topics: Adult; Azathioprine; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Prospective Studies; Reoperation; Reproducibility of Results; Survival Analysis; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2008 |
Early steroid withdrawal in pediatric renal transplantation at a single center: preliminary report.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Basiliximab; Child; Creatinine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Recombinant Fusion Proteins; Tacrolimus; Time Factors | 2008 |
Long-term graft outcome in patients with chronic allograft dysfunction after immunosuppression modifications.
Topics: Adult; Azathioprine; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Survival; Humans; Hyperlipidemias; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2008 |
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Regression Analysis; Reoperation; Retrospective Studies; Tacrolimus; Treatment Outcome | 2009 |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.
Topics: Adult; Azathioprine; Cyclosporine; Female; Glomerulonephritis; Hepatitis B Surface Antigens; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Markov Chains; Middle Aged; Monte Carlo Method; Mycophenolic Acid; Recurrence; Risk Factors; Tacrolimus; Transplantation, Homologous; Treatment Failure | 2009 |
Impact of immunosuppression on the incidence of early subclinical renal allograft rejection: implications for protocol biopsy policy.
Topics: Antibodies, Monoclonal; Azathioprine; Basiliximab; Biopsy; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Postoperative Care; Prednisolone; Recombinant Fusion Proteins; Tacrolimus | 2009 |
Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
Topics: Adult; Aged; Azathioprine; Biopsy; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Interleukin-2; Lung; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Treatment Outcome | 2009 |
AZA/tacrolimus is associated with similar outcomes as MMF/tacrolimus among renal transplant recipients.
Topics: Adult; Antimetabolites, Antineoplastic; Azathioprine; Databases, Factual; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Living Donors; Male; Middle Aged; Mycophenolic Acid; Risk; Tacrolimus; Time Factors; Treatment Outcome | 2009 |
Electrolyte free water clearance could be an early sign of renal dysfunction in renal transplant patients.
Topics: Adult; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drinking; Electrolytes; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Metabolic Clearance Rate; Middle Aged; Serum Albumin; Tacrolimus; Tissue Donors; Water | 2009 |
BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results.
Topics: Azathioprine; BK Virus; Cyclosporine; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Tacrolimus; Viremia | 2010 |
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up.
Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Liver Transplantation; Mycophenolic Acid; Patient Selection; Predictive Value of Tests; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Treatment Failure | 2010 |
Pulmonary toxicity associated with sirolimus following kidney transplantation: computed tomography findings.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Diarrhea; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Metronidazole; Mycophenolic Acid; Pneumonia; Pneumonia, Bacterial; Pneumonia, Viral; Postoperative Complications; Sirolimus; Tacrolimus; Tomography, X-Ray Computed | 2010 |
Uncomplicated strongyloidiasis in a liver transplant recipient on steroid-free immunosuppression.
Topics: Animals; Azathioprine; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Strongyloides stercoralis; Strongyloidiasis; Tacrolimus | 2010 |
Time post-lung transplant correlates with increasing peripheral blood T cell granzyme B and proinflammatory cytokines.
Topics: Azathioprine; Bronchoalveolar Lavage Fluid; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Cytokines; Drug Therapy, Combination; Flow Cytometry; Forced Expiratory Volume; Graft Rejection; Graft Survival; Granzymes; Humans; Immunosuppressive Agents; Inflammation Mediators; Interferon-gamma; Lung; Lung Transplantation; Lymphocyte Count; Prednisolone; T-Lymphocytes; Tacrolimus; Time Factors; Tumor Necrosis Factor-alpha | 2010 |
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results.
Topics: Azathioprine; Cyclosporine; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immunosuppressive Agents; Liver Transplantation; Prednisone; Retrospective Studies; Survival Rate; Tacrolimus; Treatment Outcome | 2010 |
Sirolimus addition to tacrolimus-based immunosuppression induces complete remission of post-transplant lymphoproliferative disorder in a liver transplant recipient.
Topics: Azathioprine; Female; Humans; Immunosuppression Therapy; Liver Transplantation; Lymphoma, Large B-Cell, Diffuse; Sirolimus; Steroids; Tacrolimus; Young Adult | 2010 |
Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors.
Topics: Adalimumab; Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Cytokines; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patch Tests; Prospective Studies; Tacrolimus; Treatment Outcome | 2010 |
Recalcitrant pemphigus vulgaris responding to systemic tacrolimus.
Topics: Adrenal Cortex Hormones; Aged; Autoantibodies; Azathioprine; Cyclophosphamide; Dapsone; Dermatologic Agents; Desmoglein 3; Female; Humans; Immunosuppressive Agents; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Pemphigus; Tacrolimus; Treatment Outcome | 2010 |
Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience.
Topics: Adult; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Exanthema; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Pruritus; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Neoplasms; Tacrolimus | 2010 |
Quiz page February 2011: acute kidney injury, graft pain, and subtherapeutic levels of tacrolimus.
Topics: Acute Kidney Injury; Azathioprine; Biopsy; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Pain, Postoperative; Tacrolimus | 2011 |
Steroid withdrawal in kidney transplantation: the subgroup fallacy.
Topics: Azathioprine; Contraindications; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Mycophenolic Acid; Risk Factors; Steroids; Tacrolimus; Time Factors; Withholding Treatment | 2011 |
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Diabetic Nephropathies; Female; Graft Rejection; Hip Fractures; Histocompatibility Testing; HLA-DR Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Tacrolimus; Treatment Outcome | 2011 |
"Tac"kling a difficult problem: using tacrolimus to maintain remission in ulcerative colitis.
Topics: Azathioprine; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Tacrolimus | 2011 |
Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
Topics: Adolescent; Aged; Antibodies, Viral; Azathioprine; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Hepatitis C; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Steroids; Tacrolimus | 2011 |
Mild rhabdomyolysis after renal transplantation.
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Rhabdomyolysis; Tacrolimus | 2011 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
How are thiopurines used and monitored by Swedish gastroenterologists when treating patients with inflammatory bowel disease?
Topics: Allopurinol; Antibodies, Monoclonal; Antimetabolites; Azathioprine; Drug Therapy, Combination; Female; Gastroenterology; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methyltransferases; Mycophenolic Acid; Practice Patterns, Physicians'; Surveys and Questionnaires; Sweden; Tacrolimus; Thioguanine; Tumor Necrosis Factor-alpha | 2011 |
Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.
Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Brazil; Calcineurin Inhibitors; Cyclosporine; Cytochrome P-450 CYP3A; Female; Follow-Up Studies; Gene Dosage; Genetic Association Studies; Genotype; Haplotypes; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Polymorphism, Single Nucleotide; Tacrolimus | 2011 |
Pregnancy outcomes after kidney transplantation-immunosuppressive therapy comparison.
Topics: Abortion, Spontaneous; Adult; Azathioprine; Cyclosporine; Female; Graft Survival; Humans; Immunosuppressive Agents; Infant, Newborn; Kidney Transplantation; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Stillbirth; Tacrolimus; Transplantation Conditioning; Young Adult | 2012 |
[Immunosuppressive treatment].
Topics: Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Evidence-Based Medicine; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Mycophenolic Acid; Postoperative Care; Tacrolimus; Treatment Outcome | 2011 |
Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan.
Topics: Adult; Ambulatory Care; Azathioprine; Cyclosporine; Drug Costs; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Practice Patterns, Physicians'; Prednisolone; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome | 2012 |
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database.
Topics: Azathioprine; Cyclosporine; Databases as Topic; Drug Therapy, Combination; Drug Utilization; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; National Health Programs; Practice Patterns, Physicians'; Sirolimus; Tacrolimus; Taiwan; Time Factors; Treatment Outcome | 2012 |
Successful resolution of inflammation and increased regulatory T cells in sirolimus-treated post-transplant allograft hepatitis.
Topics: Azathioprine; CD4 Lymphocyte Count; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant; Liver; Liver Transplantation; Male; Postoperative Complications; Prednisone; Retrospective Studies; Single-Blind Method; Sirolimus; T-Lymphocytes, Regulatory; Tacrolimus; Treatment Outcome | 2012 |
Maintenance therapy with tacrolimus in lupus nephritis.
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Tacrolimus | 2012 |
Cancer after heart transplant: implications for practice.
Topics: Azathioprine; Carcinoma, Squamous Cell; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Pleural Neoplasms; Prednisone; Sirolimus; Skin Neoplasms; Tacrolimus | 2012 |
Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infections; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome; Young Adult | 2013 |
Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Viral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunity, Active; Immunosuppressive Agents; Infliximab; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Male; Mercaptopurine; Methotrexate; Middle Aged; Prospective Studies; Tacrolimus | 2014 |
Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
Topics: Antibodies, Viral; Azathioprine; Brazil; Cyclosporine; Female; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Kidney Transplantation; Male; Mycophenolic Acid; Pandemics; Prospective Studies; Risk Factors; Sex Factors; Sirolimus; Tacrolimus; White People | 2013 |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought.
Topics: Adult; Aged; Anti-Infective Agents; Azathioprine; Cohort Studies; Cyclosporine; Dapsone; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Length of Stay; Male; Methemoglobinemia; Middle Aged; Mycophenolic Acid; Pneumonia, Pneumocystis; Prednisolone; Prevalence; Regression Analysis; Risk Factors; Tacrolimus | 2014 |
Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis.
Topics: Aged; Azathioprine; Cholangitis; Drug Therapy, Combination; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Pancreatitis; Steroids; Tacrolimus; Treatment Failure | 2014 |
Success with single-agent immunosuppression for multifocal choroidopathies.
Topics: Adolescent; Adult; Aged; Azathioprine; Chorioretinitis; Choroiditis; Drug Therapy, Combination; Electroretinography; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Multifocal Choroiditis; Mycophenolic Acid; Panuveitis; Prednisone; Retrospective Studies; Tacrolimus; Visual Acuity; Visual Fields | 2014 |
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen.
Topics: Adult; Azathioprine; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Middle Aged; Retrospective Studies; Tacrolimus | 2014 |
Livebirth after uterus transplantation.
Topics: 46, XX Disorders of Sex Development; Adrenal Cortex Hormones; Adult; Apgar Score; Azathioprine; Cesarean Section; Congenital Abnormalities; Embryo Transfer; Female; Fertilization in Vitro; Graft Rejection; Gynecologic Surgical Procedures; Humans; Immunosuppressive Agents; Infant, Newborn; Infant, Premature; Live Birth; Living Donors; Male; Mullerian Ducts; Pre-Eclampsia; Pregnancy; Sweden; Tacrolimus; Uterus | 2015 |
Long-Term Impact of Different Immunosuppressive Drugs on QT and PR Intervals in Renal Transplant Patients.
Topics: Adult; Arrhythmias, Cardiac; Azathioprine; Cyclosporine; Death, Sudden, Cardiac; Disease Progression; Electrocardiography; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2015 |
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Melanoma; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasms; Risk Factors; Skin Neoplasms; Survival Analysis; Tacrolimus | 2015 |
Celebrating the ACP centennial: from the Annals archive.
Topics: Azathioprine; Cyclophosphamide; Female; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mycophenolic Acid; Prednisone; Tacrolimus | 2015 |
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Topics: Academic Medical Centers; Administration, Oral; Adult; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Tacrolimus; Young Adult | 2015 |
Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study.
Topics: Adolescent; Adult; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Lupus Nephritis; Male; Mycophenolic Acid; Nephrotic Syndrome; Podocytes; Prednisone; Proteinuria; Remission Induction; Retrospective Studies; Tacrolimus; Treatment Outcome | 2015 |
[Secondary acute myeloid leukemia in a lung allograft recipient. Report of one case].
Topics: Azathioprine; Bone Marrow; Chromosomes, Human, Pair 5; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Leukopenia; Lung Transplantation; Middle Aged; Pancytopenia; Tacrolimus | 2015 |
Risk factors and incidence for lipid abnormalities in kidney transplant patients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azathioprine; Cyclosporine; Dyslipidemias; Everolimus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Mycophenolic Acid; Ribonucleosides; Risk Factors; Tacrolimus | 2015 |
Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels.
Topics: Adult; Azathioprine; Contraindications; Dose-Response Relationship, Immunologic; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Kidney Transplantation; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy, High-Risk; Tacrolimus | 2015 |
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Cholangitis, Sclerosing; Cyclosporine; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Mercaptopurine; Middle Aged; Mycophenolic Acid; Prednisolone; Retreatment; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2016 |
Adrenomedullin Therapy in Patients with Refractory Ulcerative Colitis: A Case Series.
Topics: Adrenomedullin; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Middle Aged; Pilot Projects; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Vasodilator Agents | 2016 |
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.
Topics: Adult; Agammaglobulinemia; Aged; Aged, 80 and over; Azathioprine; Bronchiectasis; Chronic Disease; Cough; Cyclosporine; Everolimus; Female; Forced Expiratory Volume; Graft Rejection; Haemophilus Infections; Haemophilus influenzae; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Polycystic Kidney, Autosomal Dominant; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Rituximab; Sirolimus; Tacrolimus; Tomography, X-Ray Computed; Vital Capacity; Young Adult | 2015 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
[Tacrolimus-induced gynecomastia in a patient with polymyositis].
Topics: Azathioprine; Drug Substitution; Drug Therapy, Combination; Gynecomastia; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Polymyositis; Prednisone; Tacrolimus | 2016 |
Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Infliximab; Tacrolimus | 2016 |
Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Chloroquine; Combined Modality Therapy; Dapsone; Diagnosis, Differential; Humans; Hydroxychloroquine; Lasers, Dye; Lupus Erythematosus, Discoid; Male; Ointments; Quinacrine; Skin; Sunscreening Agents; Tacrolimus | 2016 |
[Applied pharmacogenetic].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Azathioprine; Cyclosporine; Everolimus; Genotype; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Mycophenolic Acid; Neoplasms; Nephrology; Pharmacogenetics; Polymorphism, Genetic; Tacrolimus; Treatment Outcome | 2016 |
Liver transplant alone without kidney transplant for fibrinogen Aα-chain (AFib) renal amyloidosis.
Topics: Amyloidosis; Azathioprine; Creatinine; Female; Fibrinogen; Gene Expression; Genes, Dominant; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Liver Transplantation; Middle Aged; Mutation; Proteinuria; Tacrolimus; Treatment Outcome | 2016 |
Successful Pregnancy and Delivery in a Heart Transplantation Recipient.
Topics: Adult; Azathioprine; Drug Substitution; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Monitoring, Physiologic; Mycophenolic Acid; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Tacrolimus | 2016 |
Congenital Infections in Neonates of Women With Liver or Kidney Transplants.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant, Newborn; Infections; Kidney Transplantation; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2016 |
The use of tacrolimus in refractory autoimmune hepatitis in children and adults: a single center experience.
Topics: Adolescent; Adult; Azathioprine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Tacrolimus; Treatment Outcome; Young Adult | 2017 |
Expert clinical management of autoimmune hepatitis in the real world.
Topics: Azathioprine; Biopsy; Budesonide; Cyclosporine; Health Care Surveys; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Methyltransferases; Mycophenolic Acid; Rituximab; Tacrolimus | 2017 |
Tacrolimus 0.1% ointment applied under occlusion using cling film clears chronic actinic dermatitis resistant to systemic treatment.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents; Azathioprine; Chronic Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Occlusive Dressings; Ointments; Photosensitivity Disorders; Prednisolone; Retreatment; Tacrolimus | 2017 |
The Effect of Immunosuppression on Airway Integrity.
Topics: Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Dexamethasone; Endothelial Cells; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Interleukin-8; Lung; Lung Transplantation; Microcirculation; Mycophenolic Acid; Permeability; Tacrolimus; Tight Junctions | 2017 |
Multitarget Therapy for Maintenance Treatment of Lupus Nephritis.
Topics: Adolescent; Adult; Aged; Azathioprine; China; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus; Treatment Outcome; Young Adult | 2017 |
Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
Topics: Adolescent; Adult; Aged; Azathioprine; Brazil; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child; Cyclosporine; Dermatomycoses; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Organ Transplantation; Risk Factors; Skin Diseases, Infectious; Skin Neoplasms; Tacrolimus; Warts; Young Adult | 2019 |
Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Topics: Adult; Aged; Allografts; Antibiotic Prophylaxis; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Tacrolimus; Young Adult | 2019 |
Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Proportional Hazards Models; Remission Induction; Retrospective Studies; Tacrolimus; Treatment Outcome; Young Adult | 2019 |
Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience.
Topics: Adult; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Middle Aged; Tacrolimus; Treatment Failure; Treatment Outcome; Young Adult | 2020 |
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients.
Topics: Adult; Aged; Azathioprine; Basiliximab; Drug Administration Schedule; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Opportunistic Infections; Postoperative Care; Postoperative Complications; Prednisolone; Receptors, Interleukin-2; Renal Insufficiency, Chronic; Retrospective Studies; Risk Assessment; Tacrolimus; Young Adult | 2020 |
Gastrointestinal Side Effects of Triple Immunosuppressive Therapy Evaluated by AC Biosusceptometry and Electrogastrography in Rats.
Topics: Animals; Azathioprine; Cyclosporine; Drug Therapy, Combination; Gastric Emptying; Gastrointestinal Diseases; Gastrointestinal Tract; Immunosuppressive Agents; Male; Rats; Rats, Wistar; Tacrolimus | 2020 |
Immunotherapy choice and maintenance for generalized myasthenia gravis in China.
Topics: Adult; Aged; Azathioprine; China; Clinical Decision-Making; Cohort Studies; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Immunotherapy; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Retrospective Studies; Rituximab; Tacrolimus | 2020 |
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis.
Topics: Azathioprine; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Prednisolone; Retrospective Studies; Scleroderma, Systemic; Tacrolimus; Treatment Outcome | 2022 |
Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Disease Progression; Female; Humans; Immunosuppressive Agents; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus | 2021 |
Lung Transplant Outcomes in Adults in the United States: Retrospective Cohort Study Using Real-world Evidence from the SRTR.
Topics: Adult; Azathioprine; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Retrospective Studies; Tacrolimus; United States | 2022 |
Mycophenolate mofetil or tacrolimus compared with azathioprine in long-term maintenance treatment for active lupus nephritis.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Recurrence; Tacrolimus; Treatment Outcome | 2022 |
Pediatric Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Retrospective Cohort Study Using Real-World Evidence From the US Scientific Registry of Transplant Recipients.
Topics: Azathioprine; Child; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Patient Discharge; Retrospective Studies; Tacrolimus; Transplant Recipients | 2023 |